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The spliceosome is a large RNA-protein complex that catalyzes pre-mRNA splicing by removing 
sequences called introns and joining of the remaining sequences, called exons, to produce a 
mature mRNA. Despite over a quarter century of research on splicing, little is known about the 
compositional and conformational rearrangements, timing, and coordination of this process. 
Particularly, the pre-mRNA, which provides the template for spliceosome assembly and the 
reactive sites for splicing chemistry, has been largely ignored. This thesis utilizes single 
molecule fluorescence resonance energy transfer (smFRET) approaches on a short budding yeast 
pre-mRNA to address this challenge. Specifically, we have placed fluorescent dyes near the 
conserved splice sites that are recognized by the spliceosome and have monitored dynamic 
changes in the distance between these sites, in real-time throughout the splicing cycle.  We find 
that, contrary to conventional depictions, the splice sites are highly dynamic and explore 
reversible transitions. By stalling the progress of splicing at various steps, we have been able to 
associate unique dynamic information of the splice sites with specific steps of splicing using 
novel analysis methods that have broad applicability. We find that the splice sites explore 
reversible splice site proximity in a non-monotonic fashion throughout the process. Our results 
show that even at very early steps of splicing assembly, the splice sites are brought close together 
via a novel ATP-independent role of a helicase. Furthermore, employing a combination of 
smFRET and affinity purification (termed SiMPull-FRET), we have been able to describe the 
conformational dynamics of single isolated spliceosomes and find them to follow a biased 




at the possibility that, much like the ribosome, the spliceosome and its substrates often toggle 
between active and inactive conformations that are subsequently locked into the preferred state 
by a specific cofactor. The work presented in this thesis provides a structural and dynamic view 
of the pre-mRNA in the spliceosome, finds associated roles for protein factors, and pioneers 
single molecule techniques to answer focused questions about the mechanisms of RNA:protein 








CHAPTER 1 :Introduction 
 
1.1 RNA, the versatile biomolecule 
Nucleic acids are the biomolecules responsible for transmission of genetic information 
from one generation to another. The role of DNA as the genetic material has been well-known 
since the mid-1900s
1,2
. DNA has garnered much public attention due to its functional properties 
that make it the cell’s master molecule. In an experimental tour-de-force, the cryptic code of 
DNA was cracked, and it became immediately obvious how the genetic information could be 
passed from one generation to the next
3-6
. RNA, the messenger molecule, allows to decode the 
message stored in DNA into proteins
7
. RNA is one of the few biomolecules that can perform two 
diametrically opposite functions; code for proteins, thereby functioning as a gene; and catalyze 
reactions, thereby functioning as an enzyme. Francis Crick already had the prescience to suggest 
that apart from its role as a messenger decoding DNA, RNA could have the ability to act as an 
enzyme, which was later proved by Tom Cech
8
. Even at this now seemingly mundane role, RNA 
exhibits structural and functional variety. Messenger RNA (mRNA) faithfully copies the genetic 
material, and serves as the template for ribosomes (composed of ribosomal RNA, rRNA) to 
synthesize proteins, which in turn is aided by transfer RNA (tRNA), the adaptor molecules 












, and more 
recently the completion of the human genome project, it has become increasingly clear that RNA 
plays diverse and unexpected roles (some well-known examples shown in Table 1. 1). Given the 
relatively small fraction of the human genome dedicated to protein coding, one might expect that 
only a small fraction of the genome is transcribed into RNA as well. This is far from the truth. 
Large portions of the genome in humans and other mammals are transcribed into RNA that is not 
classified as mRNA, tRNA or rRNA. These special-function RNAs, now known as non-coding 
RNAs, are being rapidly discovered and have roles ranging from structural scaffolding to 
regulation of gene expression. This versatility has led to much speculation about a possible role 
of RNA in the origin of life
13
. 
1.2 Spliceosome, the cellular mystery machine 
1.2.1 The interrupted gene 
After the discovery of the structure of DNA, it was assumed that a gene comprised of a 
continuous sequence of base pairs that in its entirety was used as a template for protein synthesis. 
In the simplest form, a gene is a length of DNA that directly corresponds to its protein product. 
Although largely correct for bacteria, seminal discoveries in the 1970s challenged this view for 
eukaryotes
11,12
.  It was observed that the RNA transcribed from DNA in the nucleus was 
unusually long compared to the mRNA found in the cytosol. Resolution of this mystery led to 
the discovery of split genes and a process called RNA splicing. A simple yet profound 
comparison of the DNA and its corresponding RNA sequence shed light on the fact that some of 






proved that genes can be composed of several separate segments. Drs. Philip A Sharp and 
Richard J. Roberts were awarded the Nobel Prize for Physiology or Medicine in 1993 for their 
independent discovery of split genes. This discovery has been of fundamental importance to 
today's basic research in biology, as well as more medically oriented research on disease 
development and research on how genes evolve in organisms.  
1.2.2 The Ribonucleoprotein complex 
In the cellular environment, RNA is often found complexed with proteins while playing 
both structural and functional roles in biomolecular machines. A well-known example is the 
ribosome, the cellular ribonucleoprotein (RNP) complex that facilitates protein biosynthesis. 
Another example involves the highly precise removal of interviewing RNA sequences called 
introns and the ligation of the flanking sequences called exons during the process of precursor-
mRNA (pre-mRNA) splicing. This extraordinary task is carried out by a cellular RNP complex 
called the spliceosome
14
. Extensive genetic and biochemical studies in a variety of organisms 
have revealed that essential components of the spliceosome include five small RNAs – the U1, 
U2, U4, U5 and U6 small nuclear RNAs (snRNAs), each of which functions as an snRNP (small 
nuclear ribonucleoprotein). In addition to snRNPs, splicing requires many non-snRNP protein 
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The spliceosome, much like the ribosome, is an energy consuming machine, but neither 
requires NTP hydrolysis for the actual chemical reaction to take place
15
. It is intriguing to think 
that RNA may catalyze the basic chemical reaction of the spliceosome, leaving open what the 
roles of the various proteins are
16-18
. Here, once again, the similarities between the ribosome and 
spliceosome are instructive. The ribosome uses energy to power the various conformational 
rearrangements that occur in this RNP machine to ensure accuracy. Similarly, a widely accepted, 
yet untested hypothesis is that the spliceosome uses energy in terms of ATP hydrolysis to power 




1.2.3 Finding splice sites in a cellular haystack 
The spliceosome assembles anew on each pre-mRNA conserved recognition sequence
22
. 
In metazoans, the splice sites are defined as conserved sequences at the intron-exon junctions, 
that is, the 5’ splice site (5’SS) at the 5’ end of an intron, the 3’ splice site (3’SS) at the 3’ end of 
the intron, and the upstream branchsite (BS) or branchpoint (BP) (Figure 1.1). The most 
conspicuous feature of the spliceosome is that it lacks a preformed catalytic core, which is 
created in a stepwise fashion, beginning with the assembly of the U1 and U2 snRNPs at the 5’SS 
and BP, respectively, to form the pre-spliceosome (A complex). The U4/U6.U5 tri-snRNP then 
binds to create the mature spliceosome (B complex). Notably, however, U1 and U4 snRNPs 
must be removed before catalysis, creating first the activated B
act
 complex, and after additional 
rearrangements, the catalytically active B* complex (Figure 1.1). The resulting post-first-step C 






formation of mature mRNA. The chemistry of splicing occurs in a two-step transesterification 
process. In the first step, the 2’OH of the branchpoint adenosine (BP) attacks the phosphodiester 
bond at the 5’ splice site (5’SS), releasing the 5’ exon and creating the branched, lariat structure; 
in the second step, the newly generated 3’ hydroxyl of this exon attacks the phosphodiester bond 
at the 3’ splice site (3’SS), releasing the lariat intron and creating the spliced mRNA product. 
This raises an interesting molecular question of how the spliceosome finds, recognizes and 
differentiates these sequences within the plethora of RNA sequences in the cell
23
. The sequences 
constituting the splice sites provide insufficient information to distinguish true splice sites from 
the greater number of false splice sites that populate transcripts. Even the simplest eukaryote, 
Saccharomyces cerevisiae commonly known as Baker’s yeast, with its scarcity of introns that, 
when present, are short, this problem presents a potential roadblock. The answer to the mystery 
in part lies in the fact that the splice sites are only treated as global definitions of motifs while the 
spliceosome actively brings together the reactive units by manipulating the inherent structure of 
the intron in the midst of the variety surround it. In higher eukaryotes, this even more complex 
problem is simplified by the presence of auxiliary sequences that assist in highlighting the splice 
sites and aiding the spliceosome to act as a molecular bridge spanning the intron, thereby 
bringing the reactive exons together. The structure and conformations adopted by the intron play 
a critical role in regulating the progress through the splicing cycle. Although traditionally pre-
mRNA is represented as a linear sequence until after the first chemical step, this is far from the 













Figure 1.1 Canonical Splicing pathway 
Schematic representation of the stepwise assembly of spliceosome on a pre-mRNA. The 
exons (blue) are spliced and the intron (black) is removed as a lariat. The conserved 5’ 
splice site, 3’ splice site and branchpoint are shown on the pre-mRNA. DExD/H box 







1.2.4 Types of RNA splicing 
There are four well-known types of splicing mechanism prevalent in eukaryotes. The first 
two called group 1 and group 2 introns share some key characteristics but differ in the details of 
their splicing mechanism. The third and largest type of splicing involving pre-mRNA takes place 
in the nucleus via two phosphoestertransfer reactions. Although the actual chemical reaction 
itself is ATP independent, energy in the form of ATP hydrolysis is required for the various 
conformational rearrangements leading to catalysis.  This reaction is related in mechanism to the 
self-splicing mechanisms of group 1 and group 2 introns.  Specifically, group 2 introns are 
thought to be spliced by a mechanism identical to that of the spliceosome, although there is no 
general requirement for either proteins or co-factors
25
. While the fourth and last type of splicing 
involves tRNA genes that are also interrupted by introns
26
, it differs substantially in mechanism 
as it is mediated by protein enzymes with an intrinsic requirement for ATP hydrolysis.  
1.2.5 Helicases in splicing 
The spliceosome is a highly dynamic machine undergoing iterations of often mutually 
exclusive RNA-RNA unwinding events and rearrangements up until the active catalytic core if 
formed
19
. These rearrangements consume ATP and are facilitated by a large group of conserved 
RNA DExD/H box helicases. Among them, eight highly conserved helicases play crucial roles in 
key steps of splicing (Figure 1.1). These proteins are implicated in early events of spliceosome 
assembly and progression towards catalytic activation, actual catalysis and disassembly and have 
both ATP-dependent and independent roles. Among them, the ATPase activity of Sub2 is 






Branchpoint Binding Protein (BBP) proteins with the BP
27
. In an ATP independent manner, 
Sub2 also helps destabilize the Mud2-BBP heterodimer to allow for U2 snRNP binding at the 
BS. Prp5 is required for pre-spliceosome formation with its ability to bridge U1 and U2 snRNPs 
and uses ATP to cause rearrangements leading to the binding of U2 to the BP
28
. With the 
recruitment of the U4:U5:U6 tri-snRNP, the ATPase action of helicase Prp28 has been shown to 
be required for the removal of U1 from the 5’SS to allow for the mutually exclusive U6 binding 
to the 5’SS
15
. In Chapter 4, we have shown evidence for an early, ATP independent role for this 
protein in the splicing cycle. The U5 small nuclear ribonucleoprotein particle (snRNP) helicase 
Brr2 then disrupts the U4:U6 small nuclear RNA (snRNA) duplex and allows U6 snRNA to 
engage in an intricate RNA network at the active center of the spliceosome
29
. Brr2 is tightly 
regulated to ensure correct timing of spliceosome activation by its interactions with a protein 
termed Prp8, which is situated at the heart of the spliceosome
30
. Once the catalytic core is 
formed, spliceosome activation occurs wherein Prp2 is required for the first step and Prp16 and 
Prp22 are essential for the second step of splicing. The ATP dependent activity of Prp2 has been 
shown to cause a major remodeling of the spliceosome required for catalytic activation
31
. We 
found that this role is accompanied by a ratcheting motion of pre-mRNA, allowing it to explore 
close splice site proximity (Chapter 2). The next helicase Prp16 is required for the second step of 
catalysis (Appendix A) and for proofreading suboptimal substrates
30,32
. It is involved in the 
removal of Cwc25, a heat-stable protein that binds close to the BP adenosine and enhances the 
efficiency of first-step splicing (Chapter 2). Prp22 proofreads exon-ligation and mRNA 
production while Prp43 is involved in disassembling the spliceosome, allowing recycling of the 
individual components for yet another round of assembly and splicing
33,34






important regulators have been extensively characterized using genetic and biochemical tools, a 
major goal in the future is to identify their molecular mechanisms of action, as well as the 
ligands and targets required to achieve accuracy in splicing.  
1.2.6 An in vitro splicing system  
The epitome of understanding any biological system is when the individual components 
can be assembled in vitro and the desired biological effect(s) be recapitulated. The secrets of the 
spliceosome began to rapidly unravel after the important achievement of the Abelson lab to 
identify and manipulate particles (which they termed ‘spliceosome’) that splice exons in vitro
14
. 
Simply put, incubation of a pre-mRNA with crude yeast extract, in the presence of ATP, 
crowding agents and essential ions, at room temperature, results in the production of mRNA. 
This technique has been widely exploited for over 25 years to unravel the splicing mechanism. 
Crude whole cell yeast extract has been the choice material for biomolecular scientists until it 
was shown that purified spliceosome intermediates could be isolated with the aid of yeast 
genetics as a tool for stalling the spliceosome at intermediate steps. These intermediary 
complexes can be coaxed with just a handful of proteins to go through the first and second 
catalytic steps of splicing
35
. This important discovery has enabled us to assign specific functions 
to a single protein (Chapter 2). Although, due to the sheer number of components involved, we 
are still far from able to set up an entirely recombinant in vitro splicing system by adding every 
single essential component, the available in vitro splicing systems together with yeast genetics 






1.3 Single molecule fluorescence microscopy- an ideal tool for studying dynamic systems 
1.3.1 Single molecule FRET 
Major advances in understanding biological systems in recent years have been facilitated 
by the advent of single molecule (sm) techniques. These tools have opened a wide array of 
experimental avenues that were previously considered ‘unanswerable’. Sm techniques have the 
unique and powerful advantage that they are able to probe molecular structure, dynamics and 
function unhindered by the averaging inherent in ensemble experiments. The study of single 
molecules can be broadly divided into two facets; one aimed at solving scientific problems and 
the second aimed at improving the associated sm analysis techniques themselves. One of the 
most widely used sm techniques is smFRET or single molecule Fluorescence Resonance Energy 
Transfer. SmFRET is powerful and has been used extensively to study intramolecular 
dynamics
36-39
. FRET is the non-radiative transfer of energy from a donor fluorophore to an 
acceptor fluorophore in a distance dependent manner. The amount of FRET is dependent on 
several factors, but primarily on the distance (R) between the acceptor and donor dyes and their 
relative dipole:dipole orientations. FRET efficiency decreases proportionally to R
6
, where R is 
the donor:acceptor distance. The commonly used smFRET pairs Cy3 and Cy5 enable us to 
measure distances ranging from 20-100 Å, thus serving as a molecular ruler. As a result, 
smFRET techniques have found wide applications in fields ranging from quantum optics and 






1.3.2 Splice site juxtaposition using smFRET  
Each round of spliceosome assembly requires the step-by-step association and 
rearrangements of the splicing components on the pre-mRNA, the substrate on which the actual 
chemistry of splicing takes place. Thus, pre-mRNA conformations can serve as signatures for the 
different steps in the splicing cycle.  To ensure proper fidelity, it is imperative that the 
nucleotides of the 5’SS, BP and 3’SS are aligned perfectly for chemistry. Although the 
recognition of the splice sites starts at a very early step in splicing, it is unclear as to when the 
pre-mRNA is funneled into the right conformation for catalysis to occur. Any mutation of the 
splice sites can affect this conformation and thereby hinder the assembly process
40
. In order to 
understand how the splice sites are positioned throughout the splicing cycle, we used smFRET as 
detected by Total Internal Reflection Microscopy (TIRF) to validate that single pre-mRNA could 
assemble into single spliceosome complexes (Figure 1.2). By judiciously choosing the location 
of the fluorophores –both exons labeled and exon/intron labeled – we were able to focus on the 
first and second step of splicing, respectively
37
. With this in vitro assay based on smFRET, we 
were able to monitor in real-time the dynamic conformational states of the pre-mRNA in spliceo-
some assembly
37
. Furthermore, we used the powerful tools of yeast genetics to stall the 
progression of splicing at critical points in the cycle to enrich for complexes at particular points 
(Chapter 3). Upon immobilizing the pre-mRNA on the microscope slide, we were able to use 
whole cell extracts to induce and monitor splicing and ATP-dependent changes in the splice site 








Figure 1.2 SmFRET setup for studying pre-mRNA dynamics 
(a) Pre-mRNA with fluorophores at the splice sites is immobilized on a slide via a 
streptavidin-biotin linkage. Whole yeast cell extract is flowed into the channel. The Cy3 
fluorophore (green) is excited using a 532 nm laser to collect smFRET data. (b) The Cy3 
and Cy5 channels are mapped to one another to obtain information on single pre-mRNA 
molecules that are doubly labeled. (c) The anti-correlated signals from a single molecule’s 






 Due to the highly diverse and dynamic nature of the data obtained from these 
experiments, traditional sm-analysis tools were not sufficient to fully characterize them. We 
therefore used clustering algorithms to classify different behaviors (Chapter 3).  This method has 
broad potential for teasing out complex dynamics in biological systems that cannot be efficiently 
extracted using traditional sm-analysis. 
1.3.3 SiMPull-FRET, a refined look at single molecules 
Traditionally, single molecule experiments on the spliceosome have been performed 
using exogenous pre-mRNAs in yeast whole cell extracts. Recently, an elegant approach to 
combine affinity purification and single molecule techniques was described
23
. We have used a 
similar Single Molecule Pull down (SiMPull) method on the spliceosome to measure the 
proximity of the 5’SS and BS during the first step of splicing and thereby give structural 
information on the spliceosome and its remodeling (Chapter 2). In addition to being able to stall 
the spliceosome at a defined step of splicing, this technique enabled us to purify a splicing 
complex of interest from the remaining extract components for TIRF microscopy. The complex 
thus assembled on the slide surface is free from most non-specific interactions caused by binding 
and dissociation of RNA binding proteins and extraneous protein-protein interactions not 
relevant to the particular step of splicing. A prime advantage of the technique used here is that 
reconstitution of the first step is achieved by the addition of single recombinant protein, which 
allows us to specifically assign shifts in the pre-mRNA conformation to the action of single 






opportunities to investigate other steps using purified components in unusually dynamic systems 
like the spliceosome.   
The work presented in this thesis utilizes a combination of biochemical and single 
molecule FRET techniques and analysis as a way to characterize the pre-mRNA splice site 
dynamics at specific steps of splicing. We find that the 5’SS and BP come together in a non-
monotonic fashion and are kinetically modulated to enable the chemistry of splicing. The FRET 
signature we identify at each step sheds light on the conformational remodeling of the pre-
mRNA from one step to the other. Additionally, using hierarchical clustering tools, we have been 
able to identify the FRET dynamics at each step and re-create the entire conformational 
‘pathway’ followed by a single pre-mRNA in order to be efficiently spliced. Although pre-
mRNA is the prime focus, the experiments presented here also unravel unique roles for protein 
regulators in splicing. In particular, we have been able to assign novel roles to the protein Cwc25 
in stabilizing a conformation favorable to the first step of splicing. Another focus of this thesis is 
DExD/H box helicase regulators, whose mechanism of action has been largely unknown. From 
our results on Prp2 (Chapter 2) and Prp28 (Chapter 4), we hypothesize that the role of helicases 
in general may be to unlock intrinsic thermal fluctuations of the pre-mRNA:spliceosome 
complex, allowing for a ratcheting motion that is rectified by Cwc25 as a cofactor pawl. Much 










CHAPTER 2 : Biased Brownian ratcheting leads to pre-mRNA remodeling and capture 





Introns are removed by the spliceosome, a large ribonucleoprotein complex, in a two-step 
transesterification process. In the first step, the 2’OH of the branchpoint adenosine (BP) attacks 
the phosphodiester bond at the 5’ splice site (5’SS), releasing the 5’ exon and creating the 
branched, lariat structure; in the second step, the 3’ hydroxyl of this exon attacks the 
phosphodiester bond at the 3’ splice site (3’SS), releasing the lariat intron and creating the 
spliced mRNA product
14
. The most conspicuous feature of this enzyme is that it lacks a 
preformed catalytic core, which is created in a stepwise fashion, beginning with the assembly of 
the U1 and U2 snRNPs at the 5’SS and BP, respectively, to form the pre-spliceosome (A 
complex)
41
. The U4/U6.U5 tri-snRNP then binds to create the mature spliceosome (B 
complex)
41
. Notably, however, U1 and U4 snRNPs must be removed before catalysis, creating 
first the activated B
act
 complex, and after additional rearrangements, the catalytically active B* 
                                               
1Adapted from Ramya Krishnan1, Mario Blanco2, Matthew Kahlscheuer1, John Abelson3, Christine Guthrie3, Nils 
G. Walter1; ‘Biased Brownian ratcheting leads to pre-mRNA remodeling and capture prior to the first step of 
splicing’ (under review at Nat. Struct. Mol. Biol., 2013).  R.K. performed the biochemical and single molecule 
experiments. M.L.K. cloned, expressed and labeled the proteins. R.K. and M.R.B. performed data analysis. R.K., 







complex. The resulting post-first-step C complex then undergoes further remodeling required for 
the second step of splicing and the formation of mature mRNA
41
. 
The highly dynamic process of spliceosome assembly and catalysis is guided by a set of 
RNA-dependent ATPases of the DExD/H-box helicase family, which collectively function to 
insure the fidelity of splicing
15
. A major experimental challenge has been to understand the 
precise conformational rearrangements of RNA and protein that accompany each ATP-
dependent step. DExD/H-box helicase Prp2 is required for the first chemical step of splicing and 
recent proteomic analyses of the B
act
, B* and C complexes revealed that its action results in the 
destabilization of the U2 snRNP-associated proteins SF3a and SF3b
31,35,42,43
. An attractive 
hypothesis is that SF3b sequesters the BP adenosine
44
 to prevent a premature attack on the 5’SS, 
and thus the ATP-dependent action of Prp2, together with its cofactor Spp2, would be required to 
initiate catalysis. In a biochemical tour-de-force, successful reconstitution of both steps of 
splicing with the addition of recombinantly expressed proteins to immunopurified splicing 
complexes has been demonstrated
35,45,46
. In particular, first-step chemistry could be achieved 
with the addition of ATP, Prp2, Spp2 and Cwc25, a small heat-stable factor splicing factor
35
.  
We have coupled this advance with single molecule fluorescence resonance energy 
transfer (FRET) to monitor the dynamics of the pre-mRNA as the BP and 5’SS are brought into 
close proximity for first-step chemistry. We used the resulting single molecule pull-down FRET 
(SiMPull
23
-FRET) technique to analyze a functional B
act
 complex assembled on a short (135-
nucleotide) pre-mRNA with fluorophores near the scissile bonds. By assembling this complex in 




 spliceosome is stalled 






with the addition of Cwc25.  Using SiMPull-FRET, we show that ATP-dependent action of Prp2 
along with its cofactor Spp2 unlocks reversible switching of the intron between splicing-active 
and –inactive conformations. Cwc25 then rectifies this thermal Brownian ratcheting by 
stabilizing the conformation in which the 5’SS and BP are in close proximity, driving the 
equilibrium toward catalysis. 
2.2 Materials and Methods 
2.2.1 Affinity purification of the B
act
 complex 
Extracts were prepared from a prp2-1 cef1-TAP yeast strain, heated at 37 °C for 40 min 
to inactivate Prp2 and stall the spliceosome at the B
act
 complex. In a final volume of 135 μl, 40% 
(v/v) of this heat treated extract was incubated with ~50 pmoles FRET labeled Ubc4 pre-
mRNA
37
 in the presence of 2 mM ATP in splicing buffer (8 mM HEPES-KOH, pH 7.0, 2 mM 
MgCl2, 0.08 mM EDTA, 60 mM Ki(PO4), 20 mM KCl, 8% (v/v) glycerol, 3% (w/v) PEG, 0.5 
mM DTT) and incubated at 23 °C for 35 min. For biochemical experiments, streptavidin-coated 
magnetic beads (Dynabeads® MyOne™ pH 7.5, 50 mM NaCl). An equal volume of 0.5 mg/ml 
IgG-biotin (ZyMAX™ Rabbit Anti-Mouse IgG (H+L) - BT (ZyMAX™ Grade)) in T50 was 
added and incubated in a tube rotator at RT for 30 min. The beads were then pulled down using a 
magnet and the supernatant was discarded. To block any streptavidin not bound by biotin-IgG, 
the beads were incubated with excess free biotin at 1.5 mg/ml in T50 buffer in a tube rotator at 
RT for 20 min. After equilibration in splicing buffer, the independently assembled splicing 
reaction were added and incubated in a tube rotator for 30 min at RT to allow the protein A of 






supernatant, the beads were further washed three times with buffer A (20 mM HEPES-KOH, pH 
7.9, 75 mM KCl, 0.01% NP40, 1.5 mM MgCl2, 5% (v/v) glycerol) and once with splicing buffer 
to further purify the B
act
 complex. The reactions are scaled up for reconstitution reactions 
pursued in parallel and split at this step. Prp2, Spp2 and Cwc25 were added at 90-120 nM final 
concentration in splicing buffer in the presence or absence of 2 mM ATP or AMPPNP or UTP 
and incubated in the tube rotator for 30-40 min for various levels of reconstitution. RNA was 
isolated and products of splicing were analyzed on a denaturing, 7 M urea, 15% polyacrylamide 
gel and scanned on a Typhoon variable mode imager (GE Healthcare). 
2.2.2 Cloning, expression and purification of splicing factor proteins 
The full-length PRP2 gene was PCR-amplified and ligated into plasmid pRSETA 
(Invitrogen) with a C-terminal hexahistidine tag. The N-terminally truncated form of SPP2 
(coding for amino acids 37-185) containing a C-terminal hexahistidine tag, and the full-length 
Cwc25 gene were obtained from Reinhard Lührmann (Max Planck Institute for Biophysical 
Chemistry, Germany). Cwc25 was subcloned into a pRSETa plasmid containing a single 
cysteine residue and hexahistidine tag at the C-terminus. The constructs were then transformed 
into Escherichia coli strain Rossetta II (Novagen). Cultures were grown in 2-4 l of TB medium 
and induced with 125 μM IPTG. Cultures were then incubated at 20 ºC for 18 h. Cells were 
harvested, washed, and the pellets stored at -80 ºC. Purification of Cwc25-His and Spp2-His was 
performed as described
35
. Protein purity was confirmed by 16% SDS-PAGE and proteins were 
either first fluorescently labeled or directly aliquoted, flash frozen in liquid nitrogen, and stored 






His-tagged Prp2 obtained from E.coli cell lysate was purified as described
48
 Protein purity was 
confirmed by 10% SDS-PAGE and the final product aliquoted, flash frozen in liquid nitrogen, 
and stored at -80 ºC. Protein concentrations were determined by Bradford assay and 
measurement at A280. 
2.2.3 Single molecule FRET of purified spliceosomal complexes   
For the single molecule FRET experiments on affinity-purified complexes, we prepared 
slides using previously published procedures
49
. In short, the surface of a quartz slide was amino 
functionalized, PEGylated and reacted with 0.2 mg/ml streptavidin in T50 buffer for 15 min at 
RT. 100 μl of 0.5 mg/ml IgG-biotin in T50 was flowed onto the slide and incubated for 20 min, 
followed by free biotin at 1.5 mg/ml in T50 buffer for 15 min. B
act
 spliceosomal complexes were 
assembled and stalled as described above by incubation of FRET labeled Ubc4 pre-mRNA with 
heat treated prp2-1 cef1-TAP yeast splicing extract in splicing buffer supplemented with 2 mM 
ATP and an oxygen scavenger system (OSS) composed of protocatechuate dioxygenase, 
protocatechuate and Trolox
37
. These complexes were then flowed onto the slide surface and 
incubated for 15-20 min to allow the Cef-1-TAP on the spliceosome to bind biotin-IgG. The 
slide surface was washed rigorously and reconstituted (in the presence of OSS) as described for 
the biochemical purification and incubated for 10-40 min before acquiring data. A home-built 
prism-based TIRF microscope was used to collect data as described
37,50,51
. To obtain FRET data, 
we directly excited the Cy3 donor near the BP adenosine with a 532-nm laser, and we recorded 
emission by Cy3 and Cy5 fluorophores at 100-ms time resolution using an intensified CCD 






2.2.4 Fluorescent labeling of Cwc25 and distance estimation from FRET  
The single-cysteine mutant of Cwc25 was labeled with Cy5-maleimide (GE Healthcare). 
Labeling was performed using 0.150 μmol of Cwc25 in storage buffer and 0.5 mg of dye 
containing 10 μM reducing agent Tris(2-carboxyethyl)phosphine (TCEP) (Sigma). Reactions 
were incubated at RT for 1 h followed by overnight at 4 ºC. Free dye was removed by re-
purification of protein on a Ni
2+
 column and dialysis back into storage buffer. The degree of 
labeling was determined using GE Healthcare’s protocol and was found to be 70%. Protein 
functionality was confirmed using an ensemble pull down assay as described above.  The 
fluorophore distance, R, and the apparent FRET efficiency, Eapp, were calculated as 
described
50,52,53
 from the equations 
16
0 ])/(1[





















. φ and η signify the fluorophores quantum yields and detector 
channel efficiencies, respectively. The donor and acceptor intensities ICy3 and ICy5, respectively, 
were corrected for leakage of donor photons into the acceptor channel. 
2.2.5 Single Molecule Data Analysis 
The donor and acceptor intensities ICy3 and ICy5, respectively, were corrected for leakage 
of donor photons into the acceptor channel Cross-correlation analysis was carried out utilizing 
customized MATLAB scripts with built-in xcorr function. Time lags for the cross-correlation 
ranged from 0-50. Quality control for the raw smFRET trajectories obtained from the 
experimental conditions were performed as described
49
. Histograms for data sets measuring pre-






Histograms for Cwc25-Cy5 and BP-Cy3 FRET experiments were constructed by sampling the 
entire length of data. Hidden Markov Modeling (HMM) was performed on trajectories utilizing 
the vbFRET software suite
49
. Each trajectory was individually fit with models ranging from 1-5 
states with the optimal number of states determined by the vbFRET algorithm. The inherent 
experimental variations of the FRET signal between single molecules leads to a slightly different 
state assignment for similar states across different molecules. A K-means clustering approach 
was therefore performed in MATLAB to group similar states into larger macro states (L1, L2, M 
and H). A matrix cataloging the HMM assigned FRET state, raw FRET level, and difference in 
donor and acceptor intensities for each HMM derived event was utilized as input for the K-
means algorithm. A total of four macro states were identified whose boundaries were used to re-
assign the original HMM idealized FRET states. Transition Occupancy Density Plots (TODPs) 
were used to plot the fraction of molecules that contain any given HMM transition at least 
once
49
. Molecules that did not exhibit any transitions were plotted along the diagonal at their 
respective positions. For kinetic rate calculations, Transition Density Plots (TDPs) that are scaled 
by the number of times a transition occurs irrespective of how many molecules exhibit that 
transition were used as described
49
. A cumulative histogram scatter plot was then fit with a 
double-exponential association equation in MicroCal Origin. A weighted average (kw,observed) of 
the two rate constants from the double-exponential fits was calculated based on the amplitude 
values of the exponential equation. To correct for bias introduced by the limited observation 
window used to measure dwell times, the measured kw,observed values were corrected by 
subtracting the photobleaching rate constant and the reciprocal of the observation window to 
yield kw,actual as described
54






forward and backward rate constants for a set of state-to-state transitions. Post-synchronized 
histograms (PSHs) were constructed by synchronizing individual FRET events to the time where 
one of the macro-states (M, H) was achieved. The scale bar represents the fraction of FRET 
events which exhibit a certain FRET state at a given time. 
2.3 Results  
2.3.1 Immunopurification of functional complex B
act
 with fluorophore labeled Ubc4 pre-mRNA 
It has been known for almost 25 years that a prp2-1 yeast splicing extract can be heat-
inactivated
47
.  In this extract, the spliceosome is fully assembled but cannot carry out the first 
step of splicing.  The prp2-1 immature spliceosome purified by centrifugation (B
act
) was shown 
to be chased into first-step product by the addition of Prp2p and a heat stable factor(s)
45
. More 
recently, Lührmann and colleagues have repeated this experiment with purified Prp2, Spp2 and 
the (now identified) heat stable factor Cwc25
35
. Such a purified system is ideal for exploring 
substrate dynamics using single molecule FRET. To this end, we constructed a yeast strain 
containing the prp2-1 mutation and a Tandem Affinity Purification (TAP) tag derivative of one 
of the NTC components, Cef1, known to be present in the spliceosome at this stage
31,35
. This 
allowed us to purify the stalled B
act
 complex via the TAP tag.   
The Ubc4 pre-mRNA used in this study was synthesized chemically and labeled with the 
FRET donor Cy3 +6 nucleotides downstream from the BP adenosine and with the FRET 
acceptor Cy5 -7 nucleotides upstream from the 5’SS (Table 2.1). Heat inactivated whole cell 
extract from the aforementioned strain was then used to assemble splicing reactions containing 






proceed for 30 min to form the pre-catalytic B
act
 spliceosome, then bound either to streptavidin 
coated magnetic beads for biochemical analysis or to a PEG-passivated slide coated with 
streptavidin, biotin-IgG, and excess free biotin for single molecule analysis (Figure 2.1). Free 
biotin was added to block any biotin binding sites not associated with biotin-IgG and prevent 
direct binding of the 5’ biotinylated pre-mRNA to the slide. Indeed, we observed at least 11-fold 
reduced surface binding of the pre-mRNA by itself compared to the Cef1-TAP-tagged B
act
 
complex containing the pre-mRNA Figure 2.2). We detected similarly minimal non-specific 
binding of the tagged complex upon omission of IgG-biotin or when instead using a TAP-tag on 




 (Figure 2.2). To verify that our 
purification yielded functional B
act
 pre-spliceosome capable of catalyzing both steps of splicing, 
we added micrococcal nuclease (MN) treated (and thus RNA-free) whole cell extract to the 
stalled bead-purified B
act
 complex and incubated for 40 min at 23 ºC under splicing conditions. 
We found that both steps of splicing were reconstituted (Figure 2.3), demonstrating that only 
proteins are needed to chase B
act
 into splicing the FRET-labeled Ubc4 pre-mRNA. To verify that 
reconstitution of the first step of splicing could be achieved with the addition of recombinant 
proteins, we bead-purified the B
act
 complex and found it to require recombinant proteins Prp2 
and Spp2 (Figure 2.4) to yield a low level of first-step splicing products (Figure 2.1), slightly 
above that observed for the previously characterized actin pre-mRNA
35
 (Figure 2.5).  When 
additionally Cwc25 was added, a 2- to 10-fold enhancement of first-step splicing was observed 
(Figure 2.1).  Taken together, these experiments establish that FRET labeling the pre-mRNA 
substrate is compatible with the expected assembly and splicing activity of the immunopurified 
B
act







Ubc4 intron is italicized, and the allyl-amine modified uridines are denoted as (5-N-U). The 
red and green colors represent positioning of the Cy3 and Cy5 fluorophores respectively. In 
the 3’SS mutant, the bold and underlined cytosine replaces the guanine in the wildtype. 
The bold and underlined A is the BP adenosine. dSplint is the DNA splint used for 
















Figure 2.1 The SiMPull-FRET approach used here to interrogate active splicing complexes. 
The SiMPull-FRET approach used here to interrogate active splicing complexes. (a) 
Schematic showing the affinity purified B
act
 complex immobilized to a streptavidin coated 
quartz slide via biotinylated-IgG. The green and red circles on the pre-mRNA represent 
Cy3 and Cy5 fluorophores, respectively, for FRET. (b) The affinity purified B
act
 complex is 
active and can be chased through the first step of chemistry with the addition of Prp2, 
Spp2, Cwc25 and ATP. A denaturing polyacrylamide gel scanned using a variable mode 
Typhoon imager shows pre-mRNA and first-step products (the top panel shows intron-
lariat in a Cy3 scan, the mid panel shows pre-mRNA using an overlay of Cy3 and Cy5 
scans, and the bottom panel shows the 5’-exon in a Cy5 scan). Histogram quantification 







Figure 2.2 Verification of specificity of the affinity purification of single spliceosome 
complexes. 
(a) Field of view showing direct binding of the 5’ biotinylated pre-mRNA to the 
Streptavidin on the slide surface saturated with biotin-IgG and free biotin. (b) Field of view 
showing the binding of the immunopurified B
act
 spliceosome (with Cef1-TAP) to the 
streptavidin on the slide surface saturated with free biotin and biotin-IgG. (c) Field of view 
showing the binding of the immunopurified B
act
 spliceosome (with Cef1-TAP) to the 
streptavidin on the slide surface saturated with free biotin in the absence of IgG-biotin. 
Left and right panels are the Cy3 and Cy5 channels, respectively. A 532-nm laser was used 









Figure 2.3 Affinity purified B
act
 complex is active and can go through both steps of splicing. 
Lanes 1, 2 and 3 represent fractions wash, unbound and supernatant, respectively. 
Condition a is Ubc4 pre-mRNA assembled in ΔPrp2-1,Cef-I TAP extract under splicing 
conditions with ATP at 23 °C for 60 min. The B
act
 complex thus formed was affinity 
purified on streptavidin coated magnetic beads loaded with biotin-IgG. Unbound pre-
mRNA is in lane 2 and the beads are further washed to remove non-specifically bound 
components (lane 1). The remaining fraction released from the beads and incubated with 2 
mM ATP in splicing buffer is in lane 3. Condition b is wild-type pre-mRNA assembled in 
the absence of ΔPrp2-1,Cef-I TAP extract with 2 mM ATP in splicing buffer at 23 °C for 60 
min. Most of the pre-mRNA is found in the unbound fraction (lane 2). Condition c is pre-
mRNA assembled in ΔPrp2-1,Cef-I TAP extract to form the B
act
 complex as described in 
condition a. The fraction bound to the magnetic beads was then reconstituted with 
Micrococcal Nuclease (MNuclease) treated extract and analyzed in lane 3. The intron and 
intron-lariat products are observed in the Cy3 scan (left) and the mature mRNA product is 










Figure 2.4 Protein expression and purification confirmed by SDS-PAGE analysis. 
Histidine-tagged Prp2, Spp2 and Cwc25 are shown in lanes 1, 2 and 3, respectively. Cy5-
fluorophore labeled single-cysteine Cwc25 is shown in lane 4. Prp2 was analyzed on a 10% 














Figure 2.5 Affinity purified B
act
 complex formed with actin pre-mRNA shows very low 
levels of first step splicing when complemented with Prp2, Spp2 and ATP under splicing 
conditions. 
(a) 6% Urea-polyacrylamide gel scanned using a variable mode Typhoon imager showing 
pre-mRNA and 1
st
 step products in the following conditions- affinity purified B
act
 complex 
supplemented with Prp2, Spp2 and 2 mM ATP (lane 1) and Prp2, Spp2, Cwc25 (lane 2). (b) 
Quantification of lanes 1 and 2 showing a 15-fold enhancement of 1
st
 step splicing products 










2.3.2  In the B
act
 complex, the pre-mRNA is in a stable low FRET state with distal 5’SS and BP 
To obtain mechanistic insight into pre-mRNA splice site juxtaposition during the crucial 
Prp2-driven restructuring of the B
act
 complex into the catalytically activate B* complex, we 
carried out SiMPull-FRET on the slide-bound B
act
 complex (Figure 2.1) in standard splicing 
buffer. After initial quality control, FRET histograms plotted using the FRET values collected 
from 297 verified molecules over the first 100 frames (at 100 ms time resolution) indicated a 
single Gaussian distribution with an average FRET value of 0.3±0.15 (Figure 2.6). To 
objectively identify the underlying FRET states in the shot-noise dominated fluorescence signal, 
we employed Hidden Markov Modeling (HMM) as described
49
. Using a K-means approach, we 
then clustered the HMM assigned states using all the experimental conditions used in this study 
into four macro states with FRET values of 0.0-0.23 (state L1), 0.23-0.42 (L2), 0.42-0.60 (M), 
and 0.6-1.0 (H) (Figure 2.7 and Table 2.2). The dominant behavior in the B
act
 complex is a stable 
low-FRET state L2 (Figure 2.6). Transition Occupancy Density Plots (TODPs), which are scaled 
to emphasize the transitions found to be most common among a molecule population
49
, indicate 
that the stable L2 state represents the only behavior in ~52% of all B
act
 molecules (Figure 2.6). In 
addition, molecules in this state have very few transitions. To test for dynamics too fast for 
detection by HMM, we performed cross-correlation analysis between the donor and acceptor 
trajectories of each molecule and in the resulting scatter around zero found no evidence for rapid 
transitions (Figure 2.6 and Figure 2.8). Although splice site recognition begins in the splicing 
cycle as early as the commitment complex
55
 our results suggest that the 5’SS and BP in the B
act
 








Figure 2.6 In the Prp2-stalled B
act
 complex, the pre-mRNA is predominantly restricted to a 
stable low FRET state. 
(a) FRET histograms generated by binning the first 10 s of the raw single molecule FRET 
trajectories from the purified B
act
 complex. (b) Representative time traces of the B
act
 
complex with raw donor (Cy3, green), acceptor (Cy5, red), and FRET (black) trajectories 
and their idealized HMM (cyan) showing a stable L2 FRET state. The right panel of each 
molecule is the corresponding cross-correlation of donor and acceptor intensities, 
demonstrating that the HMM did not miss any donor-acceptor anti-correlated events. (c) 
Transition Occupancy Density Plots (TODPs) showing that stable L2 FRET states, which 












Figure 2.7 K-means clustering of HMM assigned FRET states. 
(a) Histogram of HMM-idealized states for each of the K-means derived clusters L1, L2, M 
and H obtained by clustering single molecule trajectories from all the experimental 
conditions (B
act
, B* and C). (b) Representative molecule showing the FRET states assigned 

















Table 2.2 K-means clustering parameters used on the HMM assigned FRET states.  
Segment number (first column) the mean raw FRET value (second column), HMM state 
(third column), and normalized difference of mean acceptor and mean donor intensities for 









Figure 2.8 Cross-correlation analysis showing the stable L2 state in the B
act
 complex with 
no significant cross correlation. 
(a) Sample trace from the B
act 
showing showing no transitions detected by HMM and no 
significant cross correlation indicating a true stable FRET state with the raw donor (Cy3, 
green), acceptor (Cy5, red), FRET (black) trajectories, idealized HMM models (cyan) and 
cross correlation analysis of donor and acceptor trajectories with time lags from 0-50. (b) 
Sample dynamic traces from the B
act 
 showing anti correlated transitions with raw donor 
(Cy3, green), acceptor (Cy5, red), FRET (black) trajectories, idealized HMM models (cyan) 






2.3.3 Prp2 mediates a large-amplitude, NTP-dependent conformational remodeling of the pre-
mRNA  
The ATPase action of Prp2 has been shown to catalyze a large conformational change 
that activates the spliceosome for the first step of splicing
31,35,45
. Spliceosomal binding of Prp2 is 
dependent on its interaction with the G patch domain of its cofactor protein Spp2
56,57
. The 
addition of Prp2, Spp2 and ATP transforms the pre-catalytic B
act
 complex into the catalytically 
active, distinctly sedimenting B* complex and results in low levels of first-step splicing
35
. To 
investigate the role of Prp2 in pre-mRNA remodeling during this step, we incubated the B
act
 
complex assembled on the slide surface with Prp2, Spp2 and 2 mM ATP (henceforth referred to 
as B* complex condition). B* complex conditions resulted in a significant shift in the FRET 
histogram toward a new ~45% population with a mean FRET value of 0.71±0.01, diminishing 
the lone 0.33±0.01 FRET distribution observed for the B
act
 complex (Figure 2.9). In contrast to 
the predominantly static L2 state of the B
act
 complex, molecules under B* conditions show 
dynamic excursions to high-FRET states, indicating that the 5’SS and BP can now reach the 
close proximity required for first-step chemistry. More specifically, the B* condition comprises 
the L2, M and H FRET states, where the H state is accessed from either the L2 or M states. 
TODP plots show that only ~11% of molecules retain the stable L2 state characteristic of the B
act
 
complex, while ~39% of molecules exhibit at least one L2→H transition. Notably, transitions 
into the H state are short-lived in a majority of molecules. However, 12% of molecules show a 
stable high FRET state, as expected if they transitioned through the first step of splicing, in 








Figure 2.9 Upon the addition of ATP, Prp2 and Spp2, the pre-mRNA is able to explore 
splice site proximity. 
(a) FRET histograms show higher FRET state sampling upon the addition of ATP and 
Prp2/Spp2 to the Bact complex, leading to formation of the B* complex. (b) Representative 
single molecule FRET time trajectories from this condition show that molecules that were 
in the stable L2 state prior to the addition of Prp2 now transition transiently to the H state 
from either the L2 state (top trajectory) or the M state (bottom two trajectories). (c) 
TODPs indicate that 11% of all molecules retain Bact-like behavior (stable L2 state), while 
a significant population explores higher FRET states. Approximately 12% of the molecules 







Prp2 can directly bind a region in the pre-mRNA downstream of the BP adenosine, even in the 
absence of ATP
58,59
. To ask whether Prp2 alone can induce the pre-mRNA remodeling observed 
here by SiMPull-FRET, we omitted either Spp2 or Prp2 from our B* conditions and found the 
resulting FRET histograms to be indistinguishable from those of the starting B
act
 complex 
(Figure 2.10). Next, we studied the role of ATP in the remodeling of the B
act
 complex. For most 
spliceosomal DExD/H-box helicases, both ATP dependent and independent roles have been 
proposed
20,60-63
. Prp2 in particular has been shown to cause significant conformational 
remodeling of the spliceosome in the absence of ATP, whereas the displacement of SF3b is ATP 
dependent
31
. To ask whether the pre-mRNA remodeling observed here requires ATP, the B
act
 
complex was incubated with Prp2 and Spp2 in the absence of ATP, leading again to no 
significant change in the FRET histogram (Figure 2.10). Similarly, when the non-hydrolysable 
ATP analog AMPPNP was used instead of ATP, the FRET histogram replicated that of the B
act
 
complex, showing that ATP hydrolysis is required (Figure 2.10). Finally, the DExD/H box 
helicases involved in spliceosomal reorganization are either integral components of snRNPs or 
extrinsic components like Prp2. Mass spectrometry studies have shown that the stalled B
act
 
complex contains stoichiometric amounts of the DExD/H-box helicase Brr2, the integral 
component of the U5 snRNP responsible for U4:U6 unwinding
64
. Direct interactions between 
Prp2 and the C-terminus of Brr2 have recently been discovered
59
, suggesting a possible role for 
Brr2 in first-step catalytic activation. To rule out that Brr2 is responsible for the observed pre-
mRNA remodeling, we exploited the fact that Brr2 is a strict ATPase
29
 whereas Prp2 is a broad 
NTPase
65
, and supplemented the B
act
 complex under B* conditions with UTP instead of ATP. 
The resulting FRET efficiency histogram is clearly distinct from that of B
act






with that of the ATP-mediated B* condition with just a slightly less efficient shift towards the 
higher FRET population (Figure 2.10). This lower efficiency is consistent with the slightly (by 
~2-fold) reduced activity of Prp2 in the presence of NTPs other than ATP
65
. Collectively, these 
results indicate that the NTP-driven helicase activity of Prp2 in complex with its activator Spp2 
causes a large structural reorganization of the pre-mRNA that allows the distal 5’SS and BP of 
the B
act























Figure 2.10 The NTPase activity of Prp2 induces structural remodeling of the pre-mRNA. 
 
FRET probability densities show that the characteristic distribution of the B
act
 complex is 
retained when B
act
 is incubated with either Spp2, Prp2, or ATP missing, or when incubated 
with Prp2/Spp2 and non-hydrolysable ATP analog AMPPNP, as indicated. By contrast, the 
addition of UTP or ATP shifts the distribution notably towards a high-FRET population 






2.3.4 Cwc25 enhances the first step of splicing by increasing the residence time in the H state 
Although the pre-mRNA is remodeled by the NTPase action of Prp2/Spp2, it does not undergo 
very efficient first-step catalysis. To further enhance first-step splicing efficiency, addition of 
Cwc25 to the B
act
 complex incubated with Prp2, Spp2 and ATP is necessary. Cwc25 was 
identified as one of a group of proteins complexed with Cef1/Ntc85 of the NTC complex. It is a 
thermostable 20-kDa protein with short coiled coil domains
66
. To determine its role in 
remodeling of the pre-mRNA, we performed SiMPull-FRET on the purified B
act
 complex 
supplemented with Prp2, Spp2, ATP and Cwc25 (henceforth referred to as C complex 
conditions). This resulted in a FRET histogram with an enhanced ~73% population with a mean 
FRET value of 0.75±0.01 (Figure 2.11). We found the FRET states under C complex conditions 
to be the same as those under B* conditions, with the L2→H and M→H transitions prevalent; 
however, the occupancy in the H state is significantly enhanced under C conditions. TODP 
analysis revealed the fraction of molecules displaying at least one L2→H and M→H transition to 
be similar under B* and C conditions, whereas the stable H state occupancy is ~3-fold increased. 
This shift is similar in magnitude to the enhancement in first-step splicing that Cwc25 induces 
(Figure 2.1), consistent with the stable H state representing the C complex after the first step of 
splicing. Post-synchronized histograms (PSHs) created by aligning the HMM-fitted traces to start 
at the M state show that the molecules under C conditions both transition more frequently to the 
H state and exhibit a higher residence time once in the H state (Figure 2.12). A similar 
comparison of transitions starting at the H state further emphasizes the stabilization of this state 
by Cwc25 under C conditions (Figure 2.12). To rule out that a change in photostabilty of 






average photobleaching time under B
act
, B* and C conditions and found them to be comparable 
(Table 2.3). To quantitatively characterize the effects of Cwc25 on the conversion of the B* to 
the C complex, we plotted the cumulative dwell times for the forward and backward L2→H and 
M→H transitions under both conditions and fit them with double-exponential functions ( 
Figure 2.13).  A comparison of the weighted average rate constant for the L2→H transition 
showed similar forward and backward rate constants under both conditions, yielding equivalent 
equilibrium constants Keq = kforward/kbackward of ~0.80. In contrast, the presence of Cwc25 
accelerates the forward and reduces the backward rate constant of the observed M→H transition, 
leading to a Keq that is ~3-fold more favorable for the H state under C compared to B* 
conditions. To show that the same pre-mRNA molecule can be chased from B* to C complex, 
we observed the same field of view before and after shifting from B* conditions (excluding 
Cwc25) to C conditions (including Cwc25) and incubating for 10 min in the dark.  Before the 
dark period, molecules were dynamically shuttling between the L2 and H states. A subset of 
molecules were observable after the dark period and of those ~50% shifted to the stable H state ( 
Figure 2.13 and Table 2.4). Taken together, our results suggest that Cwc25 acts kinetically to 
stabilize the catalytically favorable conformation, thereby effecting an enhancement of the first 














Figure 2.11 Under C complex conditions, the pre-mRNA accesses dynamic and stable high-
FRET states. 
(a) FRET probability densities plotted for molecules under C complex conditions where the 
addition of Cwc25 results in an enhanced shift to the high-FRET population. (b) 
Representative single molecule FRET trajectories from this condition show either M→H 
transitions (top panel), a stable H state (mid panel) or L2→H transitions (bottom panel), 
resulting in an overall increased residence time of the H state. (c) TODPs under this 
condition show that about 35% of the molecules exhibit a stable H state (so that they lie on 
the diagonal), which is 3-fold higher than under B* conditions, whereas the fraction of 









Figure 2.12 Cwc25 enhances the first step of splicing by stabilizing the H state. 
(a) A comparison of the aggregate molecular behavior before (B*) and after Cwc25 
addition (C) through post-synchronized histograms (PSH) with all trajectories 
synchronized to start from either the M (top) or H state (bottom) reveals a higher 
occupancy of the H state under C complex conditions. (b) (b) A comparison of the rate 
constants of the observable transitions under B* and C conditions reveals a ~3-fold 
increase in the stability of the dynamic H state for the C complex. The thickness of arrows 
corresponds to the relative rate constants. (c) Representative trajectories with transition 
dynamics from the same molecules imaged before (B*) and after Cwc25 (C) addition. 
Representative single molecule FRET trajectories with transition dynamics from the same 






min of incubation after Cwc25 addition. The data confirm that individual molecules change 























Table 2.3 Comparison of average photobleaching times and number of molecules per 
condition. 
The average photobleaching times for the B* and C complex conditions are nearly 
identical. The increase in stable high FRET states in the C complex is thus not a result of a 













Figure 2.13 Kinetic rate determination for B* and C complex transitions. 
(a) Transition Density Plots (TDPs) for the B* and C complex conditions scaled to the 
number of transitions determined by HMM. The most prominent transitions in each 
condition are L2→H, H→L2, M→H, and H→M. (b) Dwells times were extracted for each 
corresponding transition, plotted as a cumulative count plot, and fit with either a single- or 
double-exponential rate equation. The double-exponential function best approximates the 
data and was chosen for further analysis. (c) Parameters for the double-exponential 
equations fitted to the dwell time data. To reduce the dimensionality of the data, a weighted 
average rate constant kw was calculated by utilizing the amplitudes associated with each 
time constant as weighting factors. kw was used for Keq calculations and rate comparisons 


















Table 2.4 Classification of molecules from the observation of the same molecule chased 










Fraction Pre-Cwc25 addition Post-Cwc25 addition Classification
0.11 High FRET with long dwell High FRET with long dwell Catalysis of 1st step
0.39 Various behaviors (excluding
high FRET with long dwell)
High FRET with long dwell Cwc25 mediated 
enhancement
0.33 Fast Switching Slow/No switch (no 
stable high FRET)
Prp2 unbound
0.08 Fast Switching Fast Switching Cwc25 not bound






2.3.5  Cwc25 dynamically interacts with the pre-mRNA close to the BP after Prp2-mediated pre-
mRNA remodeling 
Previous studies have shown that Cwc25 binds stably to the spliceosome following Prp2 
mediated SF3a/b destabilization
43
. It seems likely that Cwc25 enhances first-step chemistry by 
binding to the pre-mRNA since mutation at the BP abolishes this interaction
32
. Additionally, 
Cwc25 has been recently shown to crosslink near the BP of the pre-mRNA
32,67
. To directly 
observe the binding of Cwc25 to the pre-mRNA we labeled the protein’s C-terminus with Cy5 
fluorophore. The Cy5 near the 5’SS of the pre-mRNA was pre-bleached so that the pre-mRNA 
had a single fluorescent Cy3 label near the BP. We tested the activity of the Cy5-tagged Cwc25 
using our bead pull-down assay and found it to be fully functional. SiMPull-FRET experiments 
were then carried out with Cwc25-Cy5 added to the B
act 
complex with and without the addition 
of Prp2, Spp2 and ATP (Figure 2.14). We observed repeated binding and dissociation of Cwc25-
Cy5 and resulting FRET with the BP under B* condition. By contrast, there was little observable 
FRET between Cwc25 and the pre-mRNA BP in the absence of Prp2/Spp2 and ATP. From the 
FRET distribution of these binding events, centered around 0.37±0.03, we estimate that Cwc25 
binds within FRET distance of the Cy3-Cy5 pair (<100 Å), roughly ~52 Å from the BP 
Adenosine. We conclude that Cwc25 activates the spliceosome for the first step by dynamically 







Figure 2.14 Prp2 mediated pre-mRNA remodeling creates a binding site for Cwc25 near 
the BP. 
(a) Schematic of our SiMPull experiment to test for binding of Cy5-tagged Cwc25 to the 






histogram under B* conditions (in the presence of Prp2-mediated remodeling) showing the 
average FRET value obtained from the experiment. The lower FRET peak centered at 0.15 
is the background associated with the system while the broader peak centered at 0.37 is the 
mean FRET between the fluorophores. (c) FRET histogram under B
act
 conditions (in the 
absence of Prp2-mediated remodeling) showing the low levels of background centered at 
0.08. (d) Representative single molecule FRET trajectories showing the binding and 
associated FRET between the Cy5 on Cwc25 and the Cy3 near the pre-mRNA BP under B
*
 
conditions. Arrows indicate binding events. (e) Representative smFRET trajectory showing 




























Here we have combined single molecule FRET between fluorophores attached near the 
5’SS and BP of the pre-mRNA substrate with affinity purification into a technique we term 
SiMPull
68
-FRET to study the spliceosomal B
act
 complex stalled by heat inactivation of Prp2.  
Stepwise addition of ATP and the recombinant proteins Prp2, Spp2 and Cwc25, which together 
are required for efficient first-step splicing and conversion of the B
act
 into first the B* then the C 
complex, revealed the role of each factor in pre-mRNA remodeling as summarized in Figure 
2.15. We find that the pre-mRNA remains in the stable low-FRET L2 state of the B
act
 complex 
(which for clarity we term L2
act
) with distal 5’SS and BP until the activation by Prp2/Spp2 in the 
presence of ATP produces the B* complex. Prp2-mediated hydrolysis of ATP (or UTP) in this 
step weakens the binding of some seven proteins, including SF3a and SF3b
31,35,42,43
 that bind the 
pre-mRNA upstream and downstream of the BP adenosine, presumably preventing its premature 
nucleophilic attack on the 5’SS. Accordingly, the B*-associated low-FRET state (L2*) allows 
the pre-mRNA to transiently and reversibly visit both mid- (M*) and high-FRET (H*) states with 
more proximal 5’SS and BP.  First-step splicing now proceeds with low efficiency, leading to 
post-catalytic C complex formation signified by a stable high-FRET state (H
C
). This finding 
indicates that the increased proximity of the reactive sites is sufficient for catalysis. However, 
reaction chemistry is significantly enhanced by the addition of Cwc25, which binds the pre-
mRNA substrate near the BP and slows particularly the rate constant of the high- to mid-FRET 
transition, leading to a longer dwell time in the pre-catalytic transient-FRET state H
C-pre






this event leads to enhanced occurrence of the stable high-FRET state associated with the post-
catalytic C complex (H
C
) (Figure 2.15). 
Our data show that before Prp2/Spp2/ATP action, the spliceosome keeps the reactive 
sites of the pre-mRNA strictly apart. This observation is consistent with and refines a recent 
report that suggested that stable splice site juxtaposition occurs some time after the NTC 
assembles on the pre-mRNA
24
. Furthermore, it has previously been speculated that the 
catalytically activated B* complex, formed after Prp2/Spp2/ATP but before Cwc25 action, may 
shift back and forth between inactive and active conformations
35
. We here have presented direct 
evidence for this notion by showing that only in the B* state dynamic excursions between low- 
and high-FRET states become observable, and only the high-FRET state places the reactive 5’SS 
and BP in close enough proximity for subsequent catalysis, correlated with the appearance of the 
stable high-FRET state H
C
. The same authors also proposed that Cwc25 binding may shift the 
equilibrium between inactive and active conformations towards the latter, which we directly 
observe and assign to a marked increase of the dwell time in the active conformation H
C-pre
 with 
proximal 5’SS and BP.  This behavior strikingly resembles that of a classical biased Brownian 
ratchet machine that draws path directionality from the stochastic thermal fluctuations to which it 
is constantly subjected, through a form of “rectification” or “biasing”
69,70
. In fact, the ribosome 
has been described as a biased Brownian ratchet machine
71-73
 and our previous single molecule 
FRET probing of pre-mRNA dynamics in whole yeast cell extract suggested that the 
spliceosome, like the ribosome, works close to thermal equilibrium
37
. We therefore propose that 
the ATP-driven helicase activity of Prp2/Spp2 acts to remove SF3a/SF3b as an impediment to 






directionality to the reaction pathway by then acting as a “pawl” to stabilize the catalytically 
competent conformation.  
DExD/H-box helicases such as Prp2 are widespread enzymes that participate in many 
aspects of RNA processing
21,74
. In general, they are thought to use ATP hydrolysis to remodel 
RNA and RNP complexes by binding, unwinding and releasing the RNA. Unlike all previous 
single molecule approaches
24,37,75-77
, our SiMPull-FRET approach allowed us to directly 
interrogate a specific intermediate of spliceosomal assembly and catalysis and discover the 
specific mechanism by which the helicase activity of Prp2/Spp2 is augmented by Cwc25. Such 
biased Brownian ratcheting may be widespread among helicase-driven RNPs, and SiMPull-




















Figure 2.15 Model for the conformational mechanism of first-step splicing.   
The 5’SS and BP of the pre-mRNA in the B
act 
complex are predominantly in the stable 
distal L2
act
 conformation with low FRET (i.e., high Cy3 and low Cy5 fluorescence, 
indicated by the green and red circles, respectively). Upon ATP hydrolysis and conversion 
into the B* complex, Prp2 along with its cofactor Spp2 unlocks the B*-associated low-
FRET state L2* to reversibly sample the mid- and high-FRET (spatially proximal) 
conformations M* and H* (and H
C-pre
 under C complex conditions). Cwc25 binds near the 
BP of the pre-mRNA, thus reducing the rate constant of the high- to mid-FRET transition 
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Excision of introns from pre-mRNA transcripts is carried out at single nucleotide 
resolution by a large and elaborate macromolecular RNP machine called spliceosome. The 
spliceosome lacks a preformed catalytic core and is assembled in a stepwise fashion from the U1, 
U2, U4, U5 and U6 small nuclear ribonucleoprotein particles (snRNPs). Each of the snRNPs 
consists of a specific small nuclear RNA (snRNA) and associated proteins. Assembly is carefully 
orchestrated in a stepwise manner on each pre-mRNA template, resulting in the formation of a 
mature mRNA in a two-step transesterification process. In the first catalytic step of splicing, the 
2’OH of the branchpoint adenosine (BP) attacks the phosphodiester bond at the 5’ splice site 
(5’SS), creating a lariat structure and a free 5’ exon. In the second step, the 3’ hydroxyl of this 
exon attacks the phosphodiester bond at the 3’ splice site (3’SS), releasing the lariat intron and 
mRNA product.  
                                               
2
Adapted from: Ramya Krishnan*, Blanco, Mario*, Joshua Martin, Matthew Kahlscheuer, John Abelson, Christine 
Guthrie, Alain Laederach and Nils Walter; “Single molecule dissection of splice site juxtaposition along the pre-
mRNA splicing cycle” (manuscript in preparation). Single molecule experiments and biochemical characterizations 
of the various blocks were carried out by Ramya Krishnan. Single molecule data pre-filtering was jointly done by 
Ramya Krishnan and Matthew Kahlscheuer. Data clustering was jointly done by Mario Blanco and Joshua Martin. 






The conserved sequences and the secondary structure of the pre-mRNA serve as template 
on which the components of the spliceosome assemble in a dynamic and highly regulated 
manner. While the focus in the field has largely been on the protein components, advances in the 
last decade in single molecule fluorescence microscopy techniques have allowed us to track the 
pre-mRNA structural rearrangements with accuracy. Notably, these studies have identified that 
components of the spliceosome are in a state of constant flux, characterized by steady-state 
dynamics and reversibility. Our previous work showed that the pre-mRNA reversibly samples a 
variety of conformations during the ATP-dependent and -independent assembly steps in splicing 
extracts. The multitude of different conformations sampled stochastically in the absence of 
molecular synchronization did, however, limit our ability to assign dynamics to specific parts of 
the assembly cycle.  
In an effort to reliably characterize pre-mRNA splice site dynamics throughout the 
splicing cycle and integrate it with the mechanistic information available, we here have 
employed a combination of genetics to stall the spliceosome at distinct stages, single molecule 
microscopy and hierarchical clustering tools to detail the 5’SS-BP conformational dynamics 
explored by the pre-mRNA throughout splicing. Using a hierarchical clustering approach to 
extract the consensus behaviors of pre-mRNAs throughout the splicing cycle, we find that the 
splice sites are dynamic and explore dynamic conformational proximity with the early assembly 
restricted to predominantly low- to mid-FRET (high- to mid-distance) states. Using these 
snippets of FRET dynamics of each splicing stall, we have recreated the entire pre-mRNA 
conformational consensus pathway in the splicing cycle. The approach presented here is widely 







3.2 Materials and Methods 
3.2.1 Synthesis of Ubc4 pre-mRNA variants 
The Ubc4 pre-mRNA variants used in this study were synthesized chemically and labeled with 
the FRET donor Cy3 +6 nucleotides downstream from the BP adenosine and with the FRET 
acceptor Cy5 -7 nucleotides upstream from the 5’SS via allyl-amine modified uridines. A DNA 
splint (dSplint) was used for templated ligation to synthesize the pre-mRNA as described
34
. The 
5’- end of the pre-mRNA is biotinylated and used for direct immobilization on the microscope 









Branch point mutant Ubc4: 
5’GAACUAAGUGAUCUAGAAAGGUAUGUCUAAAGUUAUGGCCACGUUUCAAAUGC
GUGCUUUUUUUUUAAAACUUAUGCUCUUAUUUACUACCAAAAUCAACAUGCUAU










3.2.2 Yeast extracts and modifications 
Wildtype yeast splicing extracts (Snu66-TAP background) were prepared as previously 
described
37
. U2 and U6 snRNAs were ablated as described with the following modifications
78,79
. 
DNA oligo SRU2 was used at a concentration of 400nM to achieve efficient depletion of U2 
snRNA. In vitro transcribed U2 snRNA at 50 nM concentration was then incubated with the 
depleted extract to achieve U2 reconstitution and efficient splicing. DNA oligo D1 
complementary to U6 snRNA was used at 300 mM concentration to achieve efficient depletion 
of U6 snRNA from the extract. In vitro transcribed U6 snRNA at 10 nM concentration was 
sufficient to reconstitute active splicing. Prp2-1 heat sensitive extract was incubated for 40 min 
at 37 ºC to inactivate the Prp2 protein. Each of the splicing stalls and reconstitution of activity 
were verified with ensemble splicing assays after each single molecule experiment.  
3.2.3 Single molecule measurements 
 Single molecule measurements were carried out as described
37
. The Ubc4 pre-mRNA 
used in this study were biotinylated at the 5’-end and attached directly via streptavidin-biotin 
linkage onto a quartz slide. Single molecules were selected for further analysis after verification 
that they had each a single donor (Cy3) and acceptor (Cy5) as evident from photobleaching 






sampling the first 10 seconds of each trajectory. Hidden Markov Model (HMM) analysis was 
carried out by applying a global model to the entire data set of molecules utilizing the vbFRET79 
program. The number of states allowed ranged from 1-10 and vbFRET was allowed to choose 
the final number of states, found to be 7 states. The global fit ensures that the same idealized 
FRET values are sought in all data sets, allowing for a direct comparison of state abundance and 
state-to-state transitions. 
3.2.4 Creating an HMM similarity matrix and Clustering Analysis 
 The FRET data for all conditions examined were fit with a global HMM to determine and 
assign idealized states. The HMM analysis was performed with vbFRET, allowing for the 
number of states to range from 1-10. The VbFRET algorithm determined that a total of 7 states 
exist in the system. Transition probability (TP) matrices were created for each individual 
molecule by using the path of idealized states determined by vbFRET and the hmmgenerate 
function in MATLAB. When a specific molecule did not sample a particular state that state’s 
position on the TP matrix was assigned a zero to make sure that all TP matrices have the same 
size (7 states x 7 states). The FRET Similarity Matrix (FSM) combined the TP matrix with the 
fraction occupancy of a molecule at each state (1 x 7 matrix); making the FSM an overall 7 x 8 
matrix. The FSM was then clustered using the hierarchical clustering toolbox in MATLAB. 
Before clustering, molecules sampling only one (static) state were separated and grouped 
independently because their low complexity resulted in the identification of 5 distinct static 
clusters. The pairwise distance of each molecule’s FSM was calculated using the Euclidean 






tree joined at nodes based on the median Euclidean distance between the trajectories. The 
hierarchical tree can be clustered by determining a height cutoff between pairs of nodes. We 
determined the appropriate cutoff by measuring the intra and inter cluster distances at several 
different thresholds. A threshold was chosen that resulted in 14 different clusters. These clusters 
were then joined with the 5 static clusters previously identified. Once these 19 clusters were 
identified, we could quantify the number of molecules present in each cluster under each 
experimental condition. To determine consensus behaviors for each cluster we calculated the 
mean TP matrix for each cluster and then determined the trajectory with the shortest Euclidean 
distance to that mean. 
3.3 Results 
3.3.1 Hierarchical clustering tools facilitate objective classification of complex smFRET data  
Previous smFRET studies on splice site dynamics in Ubc4 substrate have shown that the 
dynamics are time- and ATP-dependent and largely reversible
37
. More recently, work on 5'SS-
BS dynamics in RP51 pre-mRNA has shown that these sites are held farther apart from each 
other during assembly until the binding of the NTC complex, after which the splice sites explore 
close proximity
24
. We have used established genetic and biochemical tools to stall the progress 
of the splicing cycle at various steps (Figure 3.1) and observed 5’SS-BP dynamics in 
immobilized Ubc4 pre-mRNA in whole yeast cell extract  (YE). These stalls were characterized 
biochemically via standard splicing assays by incubating either the wildtype/mutant pre-mRNA 
with wildtype/mutant YE, with and without ATP for 30-40 min at 23  °C to confirm their ability 






Figure 3.5). The Ubc4 pre-mRNA used was 5’-biotinylated and labeled with a donor fluorophore 
(Cy3) at position +6 from the branchsite adenosine while maintaining the acceptor fluorophore 




Figure 3.1 Stalling the progress of splicing at various steps 
Schematic showing the assembly, activation, catalysis and disassembly of the spliceosome 
during the process of pre-mRNA splicing. Shown in red cross marks are the independent 
stalls employed in the study. The mutant pre-mRNAs (BP mutant, 5’Hyp mutant and 3’SS 
mutant) are used with wildtype extract while the other stalls have extract modifications 









Figure 3.2 Mutant pre-mRNA substrates show expected stall in the splicing cycle 
Wildtype (WT) and mutant (BP, 5’Hyp, 3’SS) Ubc4 pre-mRNA assembled in wildtype 
extract under splicing conditions without and with ATP ((-) and (+), respectively) at 23 °C 
for 60 min. RNA was extracted and the products were analyzed on a denaturing, 7 M urea, 
15% polyacrylamide gel. A variable mode Typhoon scanner was used to obtain the Cy3 
scan (left-green) and Cy5-scan (right-red). The intron and intron-lariat products are 









Figure 3.3 Depletion of U2 snRNA results in stalling of splicing cycle 
DNA oligonucleotide SRU2 is complementary to the U2 snRNA and when incubated at a 
sufficiently high concentration can deplete WT extract of U2 snRNA. (a) SRU2 at 400 nM 
was sufficient to abolish all splicing activity of WT UBC4 pre-mRNA. (b) In vitro 
transcribed U2snRNA at 50 nM was able to efficiently reconstitute activity when 










Figure 3.4 Depletion of U2 snRNA results in stalling of splicing cycle  
DNA oligonucleotide D1 is complementary to the U6 snRNA and when incubated at a 
sufficiently high concentration can deplete WT extract of U6 snRNA. (a) D1 at 300 nM was 
sufficient to abolish all splicing activity of WT UBC4 pre-mRNA. (b) In vitro transcribed 
U6 snRNA at 10 nM was able to efficiently reconstitute activity when supplemented to 










Figure 3.5 Heat-inactivated of Prp2 protein results in stalling of splicing cycle  
Prp2-1 extract carries a temperature sensitive mutation in the RNA dependent ATPase 
Prp2 that can be heat inactivated at 37 ºC for 40 min. This blocks any catalysis but allows 
assembly to proceed until just before the first step of catalysis. This block can be relieved 
















To obtain insights into pre-mRNA splice site juxtaposition up to each step where splicing 
was stalled, we performed smFRET studies on either WT or mutant pre-mRNA immobilized on 
quartz slides via streptavidin-biotin interaction. To this pre-mRNA, either the WT or modified 
yeast extract (YE) was flowed and the RNA imaged. To relieve a particular stall, we added back 
mutant extract reconstituted with the specific component and imaged the pre-mRNA. After 
initial quality control, FRET histograms were plotted using the FRET values collected from all 
verified molecules over the first 100 video frames (at 100 ms time resolution). As expected, we 
observed ATP-dependent changes in the WT pre-mRNA when incubated in YE (Figure 3.6 b 
and c). WT pre-mRNA incubated in standard splicing buffer exhibited a wide range of 
conformational dynamics with prevalence of high FRET states which are disfavored upon extract 
addition (Figure 3.6 a and b). The earliest stall in the splicing cycle was achieved by using a BP 
mutant pre-mRNA that showed a highly populated low FRET state irrespective of ATP (Figure 
3.6 d). We similarly plotted probability density histograms for all the splicing stalls used in this 
study to achieve enrichment at either the CC1 complex, CC2 complex, A complex, B
act
 complex 
or C complex stages. Our previous work had established that the conformational behaviors of 
single pre-mRNAs undergoing splicing are complex with multiple interconverting states and a 
variety of kinetic behaviors
37
. The data obtained with the 5’SS-BP labeled substrate similarly 








Figure 3.6 FRET probability histograms comparing early and late steps of splicing 
FRET histograms were plotted using the FRET values collected from all the verified 
molecules over the first 100 frames showing WT Ubc4 pre-mRNA in (a) splicing buffer, (b) 
wildtype YE depleted of ATP and (c) wildtype YE with 2 mM ATP. (d) FRET histogram 













The large amount (>10,000 single molecules) of complex data collected from these 
experiments required the use of novel analysis methods to objectively classify the similarities 
and differences between them. We created a FRET similarity matrix (FSM) by combining the 
traditional Transition Probability matrix (TP) and a histogram that describes the overall 
occupancy of states (Figure 3.7). A global Hidden Markov Model fit to all single molecule data 
collected yielded a total of seven discrete FRET states (7 x 7 TP matrix). We then created a FSM 
for each single molecule trajectory. A vector form FSM can now be used as input into clustering 
algorithms. The data sets collected for all the blocks were mixed and then a pairwise distance 
between all possible trajectories was calculated using the Euclidean distance metric. Static 
molecules (no transitions with occupancy in only one state) were then separated since their 
features are simple and can be treated separately. The Euclidean distances between FSMs for 
dynamic molecules were calculated and used to build a hierarchical cluster tree by utilizing the 
linkage function in Matlab (Figure 3.8). Molecules with short distances (high similarity) were 
grouped together and connected to other groups of molecules based on their average inter-cluster 
distance. A tree-pruning threshold was then selected based on the inter-cluster distance that 
minimized the intra-cluster distance (differences within a cluster) and maximized inter-cluster 
distance (differences between clusters) (Figure 3.9). The threshold yielded a total of 19 clusters,h 
14 of which were dynamic and 5 static. Importantly, the data were not segregated a priori by the 
experimental conditions, thereby allowing molecules with similar dynamics across conditions to 






analysis were assessed by visually verifying that similar molecules were grouped together to 




Figure 3.7 FSM: A Hidden Markov Modeling derived similarity matrix 
(a) Hidden Markov Models (HMM) can objectively and accurately analyze single molecule 
FRET signals with complex behaviors. A complex single molecule trajectory with several 
underlying states is fit with an HMM algorithm that can identify change points within the 
trajectory. (b) A simplified two-state HMM with defined transition probabilities. 
Transition probabilities describe the likelihood of any given state either transiting to 






summarizes all the pairwise probabilities and can be used to describe the kinetic behavior 
of a single molecule. (c) A FRET similarity matrix (FSM) based on a TP matrix can be 
constructed for individual molecules and used as a clustering tool. The similarity matrix 
shown here is a 7 x 7 matrix (7 idealized states) based on the TP matrix calculated for each 
molecule and a final column (column 8) which is the distribution of data points at each 
state, i.e., a histogram. The FSM of two similar molecules, depicted as heat maps, are 





















Figure 3.8 Hierarchical tree constructed from clustering single molecules 
Single-molecule FRET data were collected for each substrate and extract and globally fit 
with a 7-state HMM. An HMM similarity matrix was then constructed for each molecule 
and clustered. Molecules with only 1 state (static) were clustered separately and later 
incorporated as separate clusters. Hierarchical clustering was performed utilizing Matlab 
routines by calculating the pairwise Euclidean distance of every single molecule and 
building an agglomerative hierarchical cluster tree utilizing the unweighted average 
distance to compute distances between clusters. This tree was pruned by using a distance 














Figure 3.9 Choosing a hierarchical tree pruning threshold  
The hierarchical tree was cut several times varying the node height criterion to yield a 
range of clusters. Intra- and inter-cluster distances were computed by measuring the mean 
Euclidean distance of the trajectories to the cluster centroids formed at the various cuts. 14 
clusters were selected because there was minimal improvement in intra cluster distance 










To perform this cluster analysis with minimal user introduced bias, the linearized form of the 
FSM (i.e., the 7 x 8 matrix converted to a 1 x 56 matrix) of each molecule was plotted in its 
assigned clusters as a heat map of the values at each position in the matrix. These heat maps 
were organized such that each row represents a single molecule, while the columns are the 
different values for each point in the FSM (Figure 3.10). We found that each cluster thus 
projected has a distinct set of values for the FSM but high homogeneity within the clusters. The 
HMM fit for 20 single molecules selected at random for each cluster was concatenated into a 
single plot with vertical bars separating individual molecules. The randomly selected molecules 
within clusters have similar dynamics and illustrate the behaviors that represent each cluster 


















Figure 3.10 Vectorized FSM for each cluster 
A total of 19 clusters were derived from the clustering of single molecule splicing data. 14-
dynamic clusters, and 5-static clusters. Heat maps of the vectorized HMM similarity 
matrices for the molecules assigned to each cluster are represented here. These vectorized 
matrices (columns) represent the features that were used for clustering the individual 














Figure 3.11 Representative molecules showing dynamic behavior unique to each cluster 
Single molecules were randomly selected from each of the 19 clusters and concatenated into 
a single plot. Vertical bars serve to separate the individual molecules. The randomly 
selected molecules exemplify the typical kinetic behavior of molecules with the assigned 
cluster. As expected, the behaviors within the clusters are homogeneous and distinct from 













3.3.2 Pre-mRNA in early splicing cycle shows dynamic variation in splice site proximity 
The BP mutant substrate has an intact 5’SS that allows the U1 snRNP to bind. However, 
it blocks further assembly steps by preventing the binding of the Mud2/BBP complex at the 
branch site
44
.  The FRET histogram of the BP mutant in splicing buffer shows that it can adopt 
high-FRET conformations in the absence of any splicing component. Upon addition of YE 
depleted of ATP, the substrate becomes constrained and mainly adopts a low-FRET distribution 
(Figure 3.6). The addition of ATP does not have a dramatic effect on the FRET distribution with 
the most noticeable change manifesting as a slight increase in the abundance of high-FRET 
states. Using the data obtained from the FSM clustering, we analyzed the abundance of clusters 
(organized by ascending mean FRET value from left to right) to identify the dynamics that lead 
to the differences between conditions.  The most abundant dynamics in the BP buffer are rapid 
inter-conversions within the high FRET states (Figure 3.12). This shifts to dramatically lower 
FRET states populated by 55% of WT pre-mRNA molecules in YE depleted of ATP. The slight 
increase in the high-FRET population with the addition of ATP is due to a redistribution of 
molecules in cluster 2 to cluster 13, which exhibits the same low-FRET state but with a 
reversible excursion to the high FRET state (Figure 3.12). This systematic study allows us to link 
the extensive genetic knowledge available in the field to dynamic changes in the splice site 
proximity. Although the BP mutant pre-mRNA is recognized independent of ATP, genetic 
interactions show that the ATP-dependent DExD/H helicase Sub2p interacts early in 
spliceosome assembly
80
. Accordingly, our results imply that even at an early step, the pre-mRNA 








Figure 3.12 Conformational dynamics of early splicing stall at commitment complex 
formation 
FRET histograms and hierarchical clusters compared for the early splicing assembly stalls 
at commitment complex 1 and commitment complex 2. Clusters are reorganized based on 
mean FRET value within the cluster so the plot reads from lowest mean FRET (left) to 









According to the current understanding in the field, commitment complex 2 can assemble 
in the absence of ATP on a pre-mRNA with intact splice sites. Binding of Mud2 and BBP in 
addition to U1 snRNP now allows the pre-mRNA splice sites to sample excursions to mid-FRET 
states. However, U2 snRNA depletion, which stalls the spliceosome at CC2 similar to the 
omission of ATP from WT pre-mRNA, results in a broad sampling of several FRET states not 
restricted to low-FRET states. Since ATP is required to deplete U2 snRNA in these experiments, 
we speculate that this observation may be due to the removal of BBP-Mud2 complex by the 
ATP-dependent action of Sub2. The binding of U4:U5:U6 to the spliceosome results in the 
formation of the B complex. Depletion of U6 snRNA prevents this complex from forming and 
stalls the spliceosome at the A complex with U1 bound to the 5’SS and U2 bound to the BP 
(Figure 3.1). The most abundant dynamics (cluster 11) under these condition shows surprisingly 
low 5’SS-BP proximity, which may serve the purpose to facilitate the extensive remodeling that 
the pre-mRNA and snRNAs undergo at this step (Figure 3.13). Additionally, the 5’hyperstable 
pre-mRNA, which stabilized the interaction between the U1 snRNA and the 5’splice site and 
results in the inability of the spliceosome to exchange U1 snRNA for U6 snRNA, also leads to a 
stall at the A complex. We find that the 5’Hyp substrate in buffer has a FRET distribution that is 
lower in FRET than the BP mutant, suggesting that the 5’Hyp mutation leads to a change in the 
conformational space sampled by the naked RNA (data not shown). The addition of extract 
depleted of ATP diminishes the bulk of the high-FRET dynamics, leading to a lower FRET 
distribution (Figure 3.13). The addition of ATP has a minimal effect on the FRET distribution, 
which could be a result of the inefficient assembly of this substrate. We find that irrespective of 






cluster 8. The inability of this substrate to assemble efficiently spliceosomes even in the presence 

















Figure 3.13 Conformational dynamics of early splicing stall at A complex formation 
FRET histograms and hierarchical clusters compared for the early splicing assembly 
stalled at A complex formation. Clusters are reorganized based on their mean FRET value 











3.3.3 Pre-mRNA predominantly explores close splice site proximity during late splicing cycle 
With the spliceosome assembled on the pre-mRNA, several splicing regulators modulate 
the structure and conformation of the splice sites to facilitate the occurrence of the first chemical 
step of splicing. The exact timing and mechanism of how the splice sites are brought sufficiently 
close for chemistry is largely unknown. We performed smFRET experiments on two late splicing 
stalls at the B
act
 complex (via the Prp2_1 stall) and the C complex (via the 3’SS mutant pre-
mRNA stall). The Prp2_1 stall allows for the spliceosome to progress until the B
act
 complex 
which has the U2:U5:U6 tri-snRNP assembled on it. The DExD/H box helicase Prp2 is then 
required for the spliceosome to undergo extensive remodeling to facilitate the first step of 
chemistry
35
. The most abundant cluster under this condition is cluster 5 which samples low-, 
mid-, and high-FRET states. Although we find that high-FRET states are sampled by the pre-
mRNA at various steps of splicing, albeit at lower frequency, it is at this stage that we find this 
behavior to predominate. Results presented in Chapter III of this thesis show that the splice sites 
are brought into close proximity by the action of Prp2 protein, whereas prior to that the pre-
mRNA shows a stable ~0.4 FRET state in the B
act
 complex. The sampling of high-FRET states 
under this condition could represent the pre-mRNA being extensively remodeled in the B 
complex to achieve the final tri-snRNP composition found in the B
act
 complex conformation. We 
find that relieving this stall by the addition of Prp2 protein allows for the spliceosome to go 






The 3’SS substrate blocks exon ligation through a mutation in the AG acceptor site near 
the 3’exon. When examined under single molecule conditions, the 3’SS mutant undergoes a 
similar shift towards lower FRET behaviors from higher FRET after the addition of ATP 
depleted extract (Figure 3.14). This seems to be a general phenomenon as all three substrate 
mutants adopt lower FRET behaviors during early assembly steps. In the case of the 3’SS 
mutant, the increase in low-FRET population originates from molecules now occupying cluster 8 
as opposed to cluster 6, the predominant cluster in buffer (data not shown). Cluster 8 has 
dynamics similar to the cluster 6 found in buffer except that the transition to a higher FRET state 
is disallowed, suggesting the early assembly events are preventing the substrate from reaching 
the high FRET state, therefore leading to the lower FRET distribution. The addition of ATP 
leads to a slight shift towards high FRET that can be attributed to an increase in cluster 1 
occupancy, which exhibits rapid transitions in the high-FRET regime and a decrease in the 
abundance of molecules in clusters with low-FRET state consensus sequences. 
 To determine how similar or different the predominant behavior of the pre-mRNA that 
were relieved of a splicing stall to achieve splicing were when compared to an unblocked pre-
mRNA splicing. WT pre-mRNA was found to undergo a shift towards lower FRET states from 
the high FRET states observed in buffer upon the addition of (-)ATP extract (Figure 3.12). Upon 
addition of extract with ATP, we find that the predominant behavior shifts to high-FRET 
conformations with infrequent sampling of lower FRET states indicating proximity between the 
5’SS and BP for the first step of splicing. A comparison of the most abundant cluster for the 
WT(+)ATP data with the reconstitutions that remove the stalls introduced at CC2, A and B
act
 






these conditions are similar to those of the WT pre-mRNA (+)ATP as they populate cluster 7 
(Figure 3.15).  
 
Figure 3.14 Conformational dynamics of late splicing stall at B
act
 and C complex formation 
FRET histograms and hierarchical clusters compared for the early splicing assembly stalls 
at A complex formation. Clusters are reorganized based on mean FRET value within the 












Figure 3.15 Conformational dynamics of pre-mRNA that can proceed through both steps 
of splicing 
FRET histograms and hierarchical clusters compared for the early splicing assembly stalls 
at A complex formation. Clusters are reorganized based on mean FRET value within the 









3.3.4 Clustering analysis groups biologically similar data 
Clustering analysis allows us to objectively assess data sets by comparing the abundance 
of each cluster for each condition. We performed a similar linkage analysis on the different data 
sets collected. The abundance profile (fraction of molecules in a given cluster) for each condition 
was used as a similarity matrix for the analysis. The result of this analysis is represented by a 
hierarchical cluster tree whose leaf order is based on the similarity among conditions (Figure 
3.16). An immediate observation from this plot is that the clustering routine was able to group 
conditions that are expected to be similar to each other. In addition, our results show that both 
the BP and 3’SS mutant pre-mRNA remarkably segregate into distinct clusters of their own 
separate from the other experimental conditions. This finding alludes to a possibility that the BP 
and the 3’SS mutations are recognized very early on in the splicing cycle and that they follow a 
kinetically and conformationally distinct path from the WT pre-mRNA. WT, BP and 5’Hyp pre-
mRNA substrates in splicing buffer similarly fall into a separate branch, indicating a similarity in 
the secondary structures of these substrates, a finding that was also observed for the doubly exon 
labeled Ubc4 initially characterized by smFRET
37
. On the contrary, the 3’SS pre-mRNA, which 
can go through the first step of splicing, might need to be strictly regulated to prevent the 
formation of an aberrant mRNA. The pre-mRNA molecules in splicing buffer are in general less 
restricted than the BP mutant pre-mRNA in cell extract and often exhibit FRET dynamics that 
mimic dynamics during spliceosome assembly. Additionally, we find that the stalls employed at 
CC2, A and B
act






close together in the tree away from both early ATP independent assembly events and late 
splicing events. Finally, the wildtype pre-mRNA in extract with ATP and conditions where 
extract depletions were relieved via reconstitution allowing them to undergo splicing again, are 
grouped most closely to each other (Fig 3.15). These results highlight the sensitivity of single 
molecule measurements and the clustering analysis to differentiate inherent structural differences 











Figure 3.16 Hierarchical tree grouping the different experimental conditions  
The abundance of each cluster for each condition was used as a metric for hierarchical 













3.3.5 The splice sites sample unique conformational paths towards splicing 
The pre-mRNA dynamics that lead to chemistry must be regulated in a strict manner to 
prevent mis-splicing and achieve precision. It has been observed that close proximity of the 
splice sites, even in the absence of proteins can lead to chemistry. A WT pre-mRNA that the 
spliceosome recognizes by binding to conserved sequences must adopt a set of defined 
conformations as it progresses along the pathway. Recently, it has been proposed that the 
spliceosome exists in two distinct conformations before the first and second steps of chemistry
81
. 
In Chapter III, we describe how the pre-mRNA conformations are kinetically modulated to favor 
the first step of splicing. In order to identify the predominant conformational behavior of the pre-
mRNA at each slicing step, the consensus behavior within a cluster was determined by 
calculating the mean behavior of all the molecules within a cluster and then determining the 
single molecule with the shortest distance to the mean. These “consensus” molecules represent 
the average behavior of each of the 19 clusters (Figure 3.17). Comparison of the consensus 
behavior of the different splicing stalls as the pre-mRNA progresses along the splicing cycle is 
shown in Figure 3.18 a. We find that during early stages of spliceosome assembly, the intrinsic 
structure of the pre-mRNA is disrupted, leading to the 5’SS and BP predominantly in an 
extended conformation. However, in the presence of ATP, we find that pre-mRNA in CC2 
shows some mid-FRET excursions. Additionally, we find that upon binding of U2snRNP, the 
pre-mRNA splice sites are removed farther from each other possibly to facilitate the extensive 
snRNA:pre-mRNA rearrangements to accommodate tri-snRNP binding. The 5’SS and BP are 
then brought closer together through the addition of ATP once the spliceosome has been 






assembly, the splice sites are predominantly limited to proximal FRET conformations that 
facilitate first step of catalysis. Relieving the splicing stalls using reconstitutions show behaviors 
similar to the pre-mRNA in extract with ATP (Figure 3.18 b) indicating that even if the splicing 
cycle is stalled at certain steps, relieving the stalls allow the pre-mRNA to go through a 
conformational pathway similar to what is adopted by a wildtype pre-mRNA undergoing 


















Figure 3.17 Consensus behavior of the identified hierarchical clusters  
The pair wise distance from each molecule to the centroid of its assigned cluster was 
determined and the molecule with the smallest distance (highest similarity) to the centroid 
was plotted. These molecules represent the average or ‘consensus’ behavior of the 

















Figure 3.18 Consensus behaviors aligned with splicing cycle 
(a) The consensus behaviors of the most abundant cluster for each block is paired with the 
relevant complex enriched in the splicing cycle. (b) The predominant consensus behavior in 
the conditions where the stall was relieved using a reconstitution was similar to a wildtype 












In this study, we have collected single molecule FRET data from Ubc4 pre-mRNAs 
labeled at the 5’SS and BP that can reach various steps of splicing assembly. To achieve 
enrichment up to specific points along the splicing cycle, we introduced substrate mutations and 
depleted specific splicing factors. Stalling the progress of splicing at these specific steps allowed 
us to delineate the dynamic proximity of 5’SS and BP during the early and late steps of splicing. 
We have employed a clustering routine to tease out the multi-state dynamic behavior of the 
single molecules observed under these experimental conditions. By utilizing the transition 
probability matrix that results from Hidden Markov Modeling, we created a FRET Similarity 
Matrix (FSM) that can be utilized in hierarchical clustering algorithms to group molecules of 
similar state and kinetic behavior. This technique has enabled identification of consensus 
behaviors of molecules at various stages of splicing. We find that the WT substrate as well as the 
mutant BP, 3’SS, 5’Hyp substrates all undergo a shift to low FRET during the ATP independent 
assembly events. The BP mutant, which is stalled during the earliest stages of assembly, can only 
bind the U1 snRNP in a stable fashion and adopts the lowest FRET conformation. The WT 
substrate can undergo all the necessary assembly steps to achieve both steps of catalysis. We 
controlled the assembly of the WT substrate by depleting the extract of ATP or ablating the 
activity of the U2 snRNP, U6 snRNP, and Prp2 protein. Although the U2 snRNP ablation (∆U2) 
is expected to enrich the same complexes as the (-) ATP condition, we detected differences in the 






WT(-)ATP mirror those of the BP mutant, while the most abundant dynamics in the ∆U2 can 
now sample mid-FRET states from a low-FRET state, suggesting that the presence of ATP but 
absence of U2 snRNP has effects on the assembly of components on the pre-mRNA. Genetic and 
biochemical evidence previously established a role for the ATP dependent helicases Sub2p and 
Prp5 near the site of U2 snRNP assembly
27,60
. We attribute the differences seen here to the 
ATPase action of Sub2 located near the branchsite. However, the absence of U2snRNP prevents 
the spliceosome assembly to progress beyond this stage. The ∆U6 block allows for the assembly 
of the U2 snRNP near the branchsite enriching the A complex. Although cross-linking studies 
have shown that U2 snRNP promotes cross-intron interaction between the BP and 5’SS through 
U1-U2 snRNP interactions
28
, the results presented here show that at the A complex, Ubc4 pre-
mRNA adopts a predominantly low FRET behavior with 5’SS and BP kept apart from each 
other. This complex, however, does explore transient high-FRET excursions, possibly 
contributing to the results observed in the cross-linking studies. The stall at the B
act
 complex 
mediated by the prp2-1 mutation allows the substrate to assemble up to the point just prior to 
catalytic activation. At this stage, the most common pre-mRNA dynamics are molecules that 
sample low-, mid-, and high-FRET states. Relieving the splicing stalls with the reconstitution of 
splicing components allows the splicing cycle to proceed similar to the wildtype pre-mRNA in 
extract with ATP. The most common dynamics sampled are restricted primarily to mid- and 
high-FRET transitions with kinetics that favor the high FRET state. This suggests that the 
spliceosome components facilitate the stabilization of conformations where the 5’SS and BP are 
in close proximity during the latter stages of splicing cycle to promote catalysis. These results 






in a non-monotonic or dynamic manner with frequent excursions sampling high- and low-FRET 
states. A progressive sequence of dynamics across the spliceosome assembly landscape has 
provided us with the ability to determine the effects the spliceosomal components on the 
juxtaposition of the 5’SS and branchsite as shown in Figure 3.18.  
The novel combination of hierarchical clustering approach to understand complex single 
molecule data presented here has allowed us to group large data sets without any user input bias 
into biologically meaningful results. The analysis routine is generalizable to any set of smFRET 
data and we believe that it will become a commonly used tool as the behavior of increasingly 















Pre-mRNA is processed via the removal of intervening introns and joining of the exons in 
a two-step transesterification process called splicing. This process is catalyzed by a large and 
dynamic RNP complex termed the spliceosome that in Saccharomyces cerevisiae is composed of 
five small nuclear RNAs (snRNAs) and about 80 proteins. Exquisite precision in this process is 
imperative and derives from controlled rearrangements catalyzed by a group of RNA-dependent 
proteins called the DExD/H-box helicases. In Saccharomyces cerevisiae, eight DExD/H-box 
helicases facilitate extensive rearrangements in the spliceosome using energy from ATP 
hydrolysis, thereby ensuring splicing accuracy. By contrast, the actual chemical steps of pre-
mRNA splicing are isoenergetic and do not require ATP hydrolysis.   
 The stepwise assembly of the spliceosome components on pre-mRNA starts with the 
binding of the U1 snRNP at the 5’ splice site (5’SS) to form commitment complex 1 (CC1, 
Figure 4.1). In the next step, two proteins, BBP and Mud2 recognize and bind the branch site and 
3’ end of the intron forming commitment complex 2 (CC2). These steps do not require ATP 
                                               
3Ramya Krishnan performed the single molecule experiments and analysis. Argenta M. Price at University of 
California, San Francisco, carried out the biochemical experiments characterizing the commitment complexes. 






hydrolysis. The first ATP-dependent rearrangement occurs with Sub2, followed by Prp5, and 
U2snRNP joining to form the A complex. This event is followed by the joining of the tri-snRNP 
to form the B complex. The action of the DExD/H-box protein Prp28 then facilitates the 
exchange of U1 for U6 from the 5’SS in an ATP-dependent manner. This is followed by Prp8 
and Brr2 mediated RNA:RNA and RNA:protein rearrangements to form the catalytic core of the 
spliceosome. The actual steps of splicing are promoted by the helicases Prp2, Prp16 and Prp22, 
and finally the spliceosome is disassembled by Prp43
82
.  
 The ATP-dependent role for Prp28 in displacing U1 snRNA from the branch site has 
been extensively studied
83-86
. Both ATP-dependent and –independent roles have been proposed 
for most of the spliceosome DExD/H box helicases. Using a cold-sensitive Prp28 strain, prp28-1, 
it was found that Prp28 not only plays a role in spliceosome activation but also one of the earliest 
steps of assembly, formation of the ATP-independent Commitment Complex 2 (CC2) 
(unpublished results, A. Price et. al., 2013). In order to precisely characterize the role played by 
Prp28 in early pre-spliceosome formation, we assembled early spliceosome in the absence of 
ATP, in Prp28 depleted extracts on Ubc4 pre-mRNA labeled with fluorophores on the branch 
site and 5’SS. Our biochemical and single molecule FRET results suggest that Prp28 plays a 










4.2 Materials and Methods 
4.2.1 Splicing extract preparation  
The Prp28-depletion (ΔPrp28) strain was created by deleting the genomic copy of Prp28 
and complementing with a plasmid containing Prp28 under control of a galactose inducible 
promoter. The galactose-induced copy of Prp28 had a 3xHA tag inserted 3aa into its N-terminus, 
which partially destabilized the protein (Thesis of Pratima Raghunathan, UCSF, 1997). The yeast 
strain was grown in YEP complemented with 2% (w/v) galactose and 0.04% (w/v) sucrose, until 
reaching an OD600 of 0.5. After filtering, the cells are washed with YEP, and resuspended in 
either YEP with 2% (w/v) galactose and 0.04% (w/v) sucrose (for Wt) or in YEP with 2% (w/v) 
glucose (for ΔPrp28).  The cells were grown for 4.5 h, until the yeast were at OD ~1.8 and 
extract was prepared as described (Umen and Guthrie 1995). Extracts were checked by Western 
blot with anti-HA antibody to confirm that Prp28 was no longer detectable. 
4.2.2 Native gel analysis  
Commitment complex gels were performed essentially as described
87
, except that 
reactions were incubated at 16 °C or 23°C for 20 min in the absence of ATP. The reaction was 
run on a 3% (w/v) polyacrylamide, 0.5% (w/v) agarose, 5% (v/v) glycerol gel electrophoresis in 
0.5x TBE, run at ~5 V/cm for ~22 h in the cold. 
4.2.3 Ubc4 pre-mRNA  
Wildtype (WT) and branch point (BP) mutant Ubc4 pre-mRNA sequences were used and 






4.2.4 Expression of recombinant Prp28 (rPrp28) protein 
A 25 mL overnight culture of Rosetta II cells containing Prp28 in pRSetA vector plasmid 
was used to inoculate 3-4 L of LB broth. Bacterial cells were grown to an OD 600 of 0.5-0.7. The 
cells were then cooled to 20 °C, induced with 125 μM IPTG and incubated for 12-18 h at 18-22 
°C. The cells were then harvested and lysed in lysis buffer (50 mM Tris-HCl, pH 8.0, 300 mM 
NaCl, 10% (w/v) imidazole, 10% (v/v) glycerol). Any insoluble material was removed via 
centrifugation and the supernatant applied to Ni
2+
-NTA resin equilibrated in lysis buffer. The 
resin was then washed with lysis buffer and eluted in elution buffer (50 mM Tris-HCl, pH 8.0, 
300 mM NaCl, 150 mM (w/v) imidazole, 10% (v/v) glycerol).  The eluted rPrp28 protein was 
dialyzed against dialysis buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM EDTA, 10% 
(v/v) glycerol), snap cooled and stored at -80 °C.  
4.2.5 Single molecule FRET 
For smFRET experiments, the 5’ biotinylated pre-mRNA was attached to a streptavidin 
coated quartz slide as described in Chapter 3. Yeast ΔPrp28 extract was then depleted of any 
remaining ATP by adding Glucose at 1 mM concentration along with Oxygen Scavenging 
System as described in Chapter 3 and added to either immobilized WT or BP mutant pre-mRNA 
on a slide. The slide was then imaged as the (-ATP, Prp28Δ) condition. For Prp28 reconstitution, 
expressed recombinant Prp28 protein (rPrp28) was added to the specified concentration to 
Prp28-depleted extract and incubated for ~10 min. This reconstituted extract was then flowed 
onto a slide with Ubc4 pre-mRNA bound to flow out Prp28 depleted extract that was present. 






of any substantial anticorrelation, presence of two fluorophores, and single-step photobleaching. 
We screened transition events found within the prefiltered FRET index trajectories for localized 
anticorrelation in the donor and acceptor traces. The postfiltering system required the use of the 
HMM tool vbFRET. Post-synchronized histograms (PSHs) were constructed by synchronizing 
individual FRET events. For the titration experiments, rPrp28 at various concentrations was 
added to reconstitute the extract. Starting from the lowest concentration, this extract was flowed 
onto the slide surface, incubated for 2-5 min and imaged.  
4.3 Results 
4.3.1 Absence of Prp28 protein inhibits ATP-independent CC2 formation  
In order to investigate the role played by Prp28 in early splicing commitment complex 
formation, splicing reactions with radiolabeled RP51A pre-mRNA were assembled with either 
Wildtype (WT), Prp28-depleted (ΔPrp28), csPrp28 (prp28-1 at 16 °C) or U2snRNA-depleted 
(ΔU2) extract, in the presence and absence of ATP (+/-ATP). ). The resulting complexes were 
resolved on native gels (Figure 4.1, Price et al. 2013 in preparation). As expected, WT splicing 
reactions depleted of ATP are stalled right after CC2 formation and hence accumulate CC2, 
which migrates slower than CC1. Addition of ATP converts most of the CC2 into co-migrating 
pre-spliceosome/spliceosome (P/SP). In contrast, both ΔPrp28 and prp28-1 splicing reactions in 
the absence of ATP accumulate the majority of pre-mRNA in CC1. Upon addition of ATP to the 
prp28-1 splicing reaction, only about half as much pre-mRNA was converted to P/SP than was 






in CC1. The prp28-1 does not completely block splicing at 16 ˚C, while in the ΔPrp28 strain the 


























Figure 4.1 Depletion of Prp28 results in CC1 accumulation  
(a) Schematic of a section of the splicing cycle depicting spliceosome assembly on pre-
mRNA and the ATP-dependent role played by Prp28 in exchanging U1 for U6. (b) Native 
polyacrylamide gel showing complex formation using either WT,  ΔPrp28, cold sensitive 
prp28-1 or U2 depleted (ΔU2) extract in the absence (-) or presence (+) of ATP on RP51 
pre-mRNA (Price et al. 2013, in preperation). In the absence of Prp28 and ATP, the 












After 3.5-5 h of growth in the presence of glucose, splicing extract made from these cells no 
longer contained HA-Prp28 detectable by Western blot for HA and failed to splice at 16 ˚C. The 
accumulation of pre-mRNA in CC1 in the absence of ATP is more pronounced in the ΔPrp28 
extract. By contrast, extracts that were U2snRNA depleted, which should prevent complex A 
formation and result in the accumulation of CC2 complex, exhibits the expected behavior both in 
the presence and absence of ATP. It seems likely that the absence of Prp28 affects the 
association of BBP and Mud2 with CC1. Our results indicate that Prp28 plays an early, ATP-
independent role for Prp28 in the conversion of CC1 to CC2 and thereby commits the pre-
mRNA to splicing. To confirm that the Prp28-mediated effect seen is not limited to the RP51 
substrate, we performed a similar set of experiments using the Ubc4 substrate. In this case, 
depletion of Prp28 combined with the absence of ATP resulted in an accumulation of CC1 
complex as with RP51 substrate (Figure 4.2). To confirm that this was due to the depletion of 
Prp28, we added back rPRp28 to the extract. This however, only resulted in a marginal increase 
of CC2 band (adding back rPrp28 in both RP51 and Ubc4 has been unsuccessful in our hands to 
date). A wildtype control depleted of ATP, as expected resulted in the accumulation of CC2 
band. However, when Prp28 was depleted and ATP present in the extract, the resulting effect 
caused an accumulation of CC1 instead of the P/Sp band, consistent with our hypothesis. If 
Prp28 only has a late, ATP-dependent role in splicing, depletion of Prp28 should have resulted in 
the pre-spliceosome accumulation as with a wildtype control extract in the presence of ATP 







4.3.2 Prp28 allows the 5’SS- BP to explore conformations of close proximity 
To investigate the role of Prp28 in CC2 formation and the effect on pre-mRNA 
conformation, we chose Ubc4, our well-studied pre-mRNA with fluorophores near the 5’SS and 
BP (as described in Chapters 2 and 3). The WT pre-mRNA was biotinylated at the 5’end and 
immobilized on a streptavidin coated quartz slide. Splicing reactions were assembled in the 
ΔPrp28 extract in the absence of ATP (-ATP) and flowed onto the slide (Figure 4.3). After initial 
imaging, the ΔPrp28 extract was reconstituted with recombinantly expressed rPrp28 protein at 80 








Figure 4.2 Inhibition of CC2 formation in the absence of Prp28 in Ubc4 pre-mRNA 
Yeast extract assembled on radiolabeled Ubc4 pre-mRNA in either Prp28-depleted extract 
(ΔPrp28) or wildtype (WT) extract analyzed on a 3% acrylamide, 0.5% agarose, 5% 












Figure 4.3 SmFRET set-up and representative traces 
(a) Schematic of the smFRET experiment showing Ubc4 pre-mRNA immobilized via the 5’ 
biotin onto a streptavidin coated quartz slide. ΔPrp28 extract in the absence of ATP (-ATP) 
or the same extract reconstituted with rPrp28 is flowed onto the slide and imaged. (b) 
Representative single molecule traces from ΔPrp28 (-ATP) and ΔPrp28 (-ATP) 
reconstituted with 80 nM recombinantly expressed Prp28 protein. Red trace represents 












Representative single molecule traces from these conditions show anti-correlated behavior under 
both conditions (Figure 4.3). FRET  probability histograms plotted by sampling the first 100 
frames of each single molecule trajectory show that under Prp28-depleted condition, the pre-
mRNA exhibits a bimodal distribution with centers at ~0.21 and ~0.7 (Figure 4.4). Addition of 
rPrp28 induces the pre-mRNA molecules to explore higher FRET states (Figure 4.4). Post-
synchronized histograms (PSHs) also show that high FRET transitions are favored in the 
presence of rPrp28 (Figure 4.5). 
 We next assembled early spliceosomes in the absence of ATP in the branchpoint A-to-C 
mutant (BP) pre-mRNA substrate and imaged it under single molecule conditions. Substrates 
with mutant or missing branchpoint regions are known to only form the CC1 complex
88
, since 
the association of the branchpoint binding protein (BBP) and Mud2 are dependent on the 
presence of an intact BP sequence
89,90
. If the high FRET transitions observed in the WT pre-
mRNA to be induced by rPrp28 were representative of 5’SS-BP proximity in CC2, then these 
transitions should be absent from the BP mutant substrate since the lack of a correct BP sequence 
prevents Mud2-BBP complex from binding it. FRET probability histograms show that, in the 
absence of ATP, ΔPrp28 extract assembled on BP mutant pre-mRNA shows a bimodal 
distribution that does not change significantly with the addition of rPrp28 protein (Figure 4.5). 
This result supports the conclusion that Prp28 is indeed responsible for driving the proximity 
between 5’SS and BP in WT pre-mRNA. Pre-mRNA in CC1 may be in equilibrium between 
high- and low-FRET states, and rPrp28 drives this equilibrium towards CC2 signature wherein 









Figure 4.4 Addition of rPrp28 protein shifts the 5’SS-BP of Ubc4 pre-mRNA to explore 
conformations of close proximity   
FRET histograms generated by binning the first 10 s of the raw single molecule FRET 
trajectories from doubly labeled Ubc4 pre-mRNA imaged under (a) ΔPrp8, (-) ATP extract 
and (b) ΔPrp8, (-) ATP extract incubated with 80 nM rPrp28 protein. Transition Density 
Plots (TDPs) show that the predominant transition under condition a is restricted to low 
FRET ranges while condition b shows more higher FRET transitions. Transition 
Occupancy Density Plots (TODPs) depicting all the transitions encountered by the 









Figure 4.5 Post-synchronized histogram showing the increase in the high FRET transitions 
upon rPrp28 addition 
Post-synchronized histograms of pre-mRNA dynamics in the absence of ATP in either (a) 
















Figure 4.6 BP mutant 5’SS-BP dynamics are not affected by Prp28  
FRET histograms generated by binning the first 10 s of the raw single molecule FRET 
trajectories from doubly labeled BP mutant Ubc4 pre-mRNA imaged under conditions of 


















4.3.3 Titration of various concentrations of Prp28 shifts the equilibrium 
To assess if the addition of rPrp28 indeed shifts the equilibrium between the high- and 
low-FRET states observed in the pre-mRNA traces, we added increasing concentrations of 
recombinant rPrp28 to Ubc4 pre-mRNA incubated with ΔPrp28 extract in the absence of ATP. 
In the absence of rPrp28, the probability histogram of 5’SS-BP dynamics shows bimodal 
sampling of both high- and low-FRET states. Addition of 20, 40 and 80 nM rPrp28 biases this 
sampling increasingly towards the high-FRET state (Figure 4.7). The 40 nM and 80 nM rPrp28 
concentrations do not significantly differ in the equilibrium between these states. It appears that 
very low concentrations of rPrp28 are sufficient to drive the equilibrium towards high-FRET 













Figure 4.7 Pre-mRNA dynamics analyzed with varying concentrations of Prp28 
FRET probability histograms showing 5’SS-BP FRET distributions at varying 









DExD/H box helicases have been studied quite extensively in recent years. It has become 
clear that we still have a long way to go before fully understanding them. Questions ranging 
from what is their mechanism of action to what is their substrate remain unanswered. The 
spliceosomal DEXD/H-box proteins have been shown to function at different points in the 





 Prp22 and Prp16
32
. In the work presented here, we have shown that Prp28 
plays an early, ATP-independent role in spliceosome assembly in addition to its well-known 
ATP-dependent role in substituting U1 for U6 snRNP
85,93
. We show that Prp28 promotes the 
formation of CC2 complex. The 5’SS and BP of pre-mRNA assembled in CC1 toggle between 
low-FRET (distal) and high-FRET (proximal) states. Binding of the Mud2-BBP complex and 
conversion to CC2 pushes the conformation to closer proximity (high-FRET state). We show that 
rPrp28 induces this change possibly by stabilizing BBP and Mud2 binding on the branchsite of 
the pre-mRNA during CC2 formation, since a BP mutant pre-mRNA does not show a Prp28-
dependent high-FRET state. We believe that this principle of toggling might be a common theme 
that the spliceosome exploits to achieve precision
94
 (Chapter 2). 
Another approach that can be used to tease out the hypothesis is to use extract from a U1-TAP 
yeast strain. Using a pre-mRNA assembled in this extract in the absence of ATP, we can affinity 
purify any complex that is bound by U1snRNP in the absence of ATP, the CC1 and CC2 
complex. Using a similar set up, in the presence of the BP mutant pre-mRNA, we can purify the 
CC1 complex. After purification, one half of this can be run on a native gel after TEV protease 






molecule microscope for side by side comparison of signatures of CC1 and CC2 in Ubc4 
substrate. Once definitive signatures of CC1 and CC2 are obtained, a variety of routes can be 
taken to confirm if CC2 formation is enhanced by Prp28.  We could deplete the pulled down 
complex in the absence of ATP of any Prp28 using a specific antibody and then analyze the 
complexes using smFRET or make the ΔPrp28 strain in the U1-TAP background.  
The results presented in Chapter 2 hint towards the possibility that the 5’SS and BP in Ubc4 pre-
mRNA only come into close proximity after remodeling by Prp2. The experiments presented 
there with Ubc4 substrate in wildtype extract (Snu66-TAP background) under conditions of ATP 
depletion and U2snRNA depletion should essentially be signatures of CC2 complex. However, 
we find that under these conditions, 5’SS and BP of Ubc4 are still farther apart from each other. 
If according to the results presented here, Prp28 drives the spliceosome to form and possibly 
stabilize CC2 complex, this should result in low FRET states population. However, we find this 
not to be the case. There could be several reasons for this; 1) the splicing extracts used under 
these two experimental conditions might have slightly altered spliceosome to pre-mRNA 
stoichiometry. To resolve this, a wildtype extract with the same background as the ΔPrp28 strain 
needs to be tested in the absence of ATP. 2) Another possibility is that these experiments were 
carried out at 80 nM Prp28. If Prp28 stabilizes CC2 formation in a concentration dependent 
manner, the conditions used in these experiments could be overly saturating. If this is the case, 
Prp28 reconstitution experiments should be done at a lower concentration of Prp28.  
Additionally, our preliminary results from using a Prp28 mutant with a single cysteine labeled 
with a fluorophore shows that even in the absence of ATP, Prp28 binds the 5’SS of the pre-






labeled Prp28 varies in the presence and absence of ATP are required to kinetically assess the 
mechanism of Prp28-mediated early complex formation.   
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CHAPTER 5 : Summary and Outlook 
 
 
5.1 Pre-mRNA splice site dynamics using smFRET and SiMPull-FRET 
Structural information about the spliceosome has largely been derived from electron 
microscopy images of stable complexes
95
. Recently crystallization of spliceosome components 
like Prp8, known to be at the heart of the spliceosome are providing clues into how this 
enigmatic machine functions
30,81,96
. However, the pre-mRNA so far is largely excluded from 
these studies. Although some efforts have been made towards mapping the position of the splice 
sites in these complexes
97
, these at their best, capture only static images of the system. The 
dynamics of any biological system hold the key to how it actually functions. The results 
presented herein on pre-mRNA dynamics clearly reveal that splice sites transiently and 
reversibly sample close splice site proximity many times throughout the splicing cycle (Chapters 
2, 3 and 4). Some of the early biochemical experiments meant to probe splice site proximity 
pointed towards a possibility where the splice sites were brought close together very early in the 
splicing cycle
98,99
. Our results show that the splice sites adopt close proximity only after the 
action of Prp2 (Chapter 2). Careful analysis of FRET dynamics provides vital insights into the 







 In this thesis, we have described the use of two different techniques to understand pre-
mRNA dynamics - one, a direct attachment of 5’ biotinylated pre-mRNA on a streptavidin 
coated quartz slide and the other, more recently developed, SiMPull-FRET, where the 
immunopurification of a complex is followed by an antibody mediated immobilization on a 
quartz slide. Direct immobilization of pre-mRNA has its advantages in that it is simple and 
allows the user to change the experimental conditions simply by flowing in and out different 
variations of extracts and mutants. While it does not allow for the same flexibility in varying the 
conditions, SiMPull-FRET on the other hand offers a cleaner system to address focused 
questions to associate specific FRET changes with single components. To the best of our 
knowledge, this is the first time smFRET dynamics has been studied in the spliceosome using a 
purified system. Both techniques have provided the field with significant advancement as tools 
for investigating mechanistic details of various stages of splicing and are fully extendable to 
other biomolecular systems.  
5.2 Focusing on the first and second step splicing complexes 
In order to gain insights into the structure of the spliceosome and the mechanism by which 
splicing occurs, significant efforts in recent years have been directed at the catalytic steps 
themselves
31,32,35,43,59,100,101
. It is known that conformational change in the spliceosome precedes 
both catalytic steps of splicing. In Chapter 2, we have focused on the pre-mRNA dynamics at the first 
step of splicing by assigning specific roles to the proteins known to be involved in this. Specifically, 
we have shown that Prp2 acts to remodel the pre-mRNA bringing about a large conformational 






what the target of Prp2 could be. One speculation is that Prp2 remodels the spliceosome by 
weakening the protein interactions near the BP. One of the critical snRNA-pre-mRNA interactions 
in the spliceosome involves a short duplex between the U2 snRNA and the BP region where the 5′ 
end of the U2 snRNA contains a sequence complementary to the BP, with the exception of a bulged 
branchpoint adenosine44,102. It has been proposed that in order to avoid a premature attack, the 
adenosine residue is thought to be physically sequestered by the SF3b subcomplex, one of the two 
multimeric protein complexes required for the addition of U2 snRNP during pre-spliceosome 
formation31. Structural reorganization of the spliceosome by Prp2 possibly displaces SF3b protein 
allowing for the BP to become accessible for the first step chemistry to occur. This hypothesis could 
be tested by smFRET between a labeled SF3b protein and pre-mRNA substrate with a fluorophore 
label near the BP in the presence and absence of Prp2. In human spliceosomes, structural analysis 
have shown that SF3b complex crosslinks to the BP adenosine
103
. If according to the proposed 
model the BP is sequestered by SF3 sub-complex, we would be able to look for direct interactions 
between BP and the labeled protein which should subsequently get altered with the addition of Prp2.  
Another interesting facet to explore is the mechanism by which Prp2 as a helicase mediates 
the displacement of SF3b. One model is that Prp2 slides along the BP of the pre-mRNA fulfilling its 
role as a helicase much like Prp22104, weakening the U2-BP base pairing and thereby destabilizing 
SF3b subcomplex. To test this, we can utilize the SiMPull-FRET set-up assembled using the heat 
inactivatable Prp2-1 extract that has been reconstituted with 5’-end labeled U2 snRNA as described 
in Chapter 2. Ubc4 pre-mRNA with fluorophore near the BP assembled in this set-up can essentially 
serve as a single molecule helicase assaying system to test if the addition of Prp2 (possibly ATP-
dependent) weakens the interaction between U2 snRNA and pre-mRNA. On the contrary, our 






pre-mRNA (as shown in Chapter 2) to destabilize SF3b. This testable hypothesis will provide vital 
clues to what the target of this important first step protein might be.  
In Chapter 2 we have shown that Cwc25, a protein whose mechanistic roles functions were 
unknown, plays a prime role in kinetically modulating the spliceosome towards enhanced first step 
catalysis. Our findings indicate that Cwc25 does this by binding to a site within FRET distance to the 
BP of the pre-mRNA (Figure 3.14). However, binding a dissociation of Cwc25 evidences the 
transition between first and second step catalytic conformational switches. With the singly labeled 
Cwc25, we can address kinetically when and how long Cwc25 is bound near the BP prior to the first 
step. Which factors are responsible for the removal of Cwc25 bound near the BP in Ubc4 pre-
mRNA, where the distance between the BP and 3’SS lies somewhat in between the longer and 
shorter version of actin substrates previously used100. Additionally, we can also explore if the 
displacement of Cwc25 is mediated by the ATPase action of the helicase Prp16 by using an ATPase 
deficient Prp2 mutant.   
With the reconstitution of second step of splicing, it can become clear that the spliceosome 
exploits structural reorganizations to regulate chemistry. Our findings detailed in Chapter 2 show that 
prior to the first step of splicing, Prp2, in an ATP-dependent manner mediates a large conformational 
change in the pre-mRNA itself. Similarly, does the second step helicase Prp16 mediate a 
conformational change in the pre-mRNA, possibly bringing the 3’SS and 5’SS close together? If so, 
is the role of other second step factors (Prp18-Slu7) to stabilize the second step conformation?  
SiMPull-FRET offers easy means to answer these questions by simply immobilizing the Bact complex 
as described earlier with the sequential addition of step 1 and step 2 factors while imaging the pre-
mRNA. In order to image single molecules throughout this process, a traditional continuous exposure 






extremely challenging in our previous experiments (Figure 3.12 c). To circumvent this, we will use 
time-lapse illumination and increase our observation window with short exposures where we 
capture dynamics and longer dark periods with no illumination that can be used to image pre-
mRNA molecules to an hour in buffer conditions. Alternatively, we could use dyes with 
enhanced photostability that have a proximal protective agents linked to it instead of the 
traditional cyanine dyes as described
105
. It would be interesting to observe how Prp16 affects the 
molecules with a stable high FRET state (post-first step chemistry) versus those molecules that 
are still toggling between high and mid-FRET states (Prp2-induced) even after Cwc25 addition, 
providing clues towards how Prp16 mediates proofreading.  
The catalytic center of the spliceosome holds several secrets. With the recent crystal structure 
of Prp8 protein, a highly conserved factor known to be at the active site of the spliceosome81, it has 
been increasingly evident that the RNaseH-like domain on this protein could be important either as 
the docking site for catalytic events or directly take part in catalysis. It has been proposed that Prp8 
has two alternative states that facilitate either the first or the second step106,107. In a screen for the 
identification of suppressors of splicing defects caused by pre-mRNA mutations, Prp8 suppressors 
were identified, that can rescue or suppress first step and second step splicing defects106,108. First step 
alleles favor the first step, accumulate intermediates and produce very little mRNA.  Second step 
alleles favor the second step, result in very little intermediates but make second step products. Some 
of the suppressors of 5’SS, 3’SS and BP mutations map to the b-finger of the RNaseH-like domain81. 
This domain has been shown to assume several different conformations which in theory could be 
relevant for the transition between first and second steps of splicing. It is plausible that the 






mRNA towards catalysis. Our SiMpull-FRET set up offers a way to test if in the presence of extract 
with the first step alleles, the pre-mRNA adopts conformations favorable for the first step as opposed 
to the second step and conversely, in the presence of extract with second step alleles, the pre-mRNA 
adopts conformations favorable for the second step. If this is true, it could mean that either these 
suppressor mutations of Prp8 are directly involved in catalytic steps of splicing or that these mutant 
residues encourage the rearrangements in the RNA structure necessary for catalysis.  
5.3 Labeling pre-mRNA and proteins for smFRET studies 
The ability to site-specifically attach fluorescent dyes to proteins and nucleic acids is 
crucial for understanding their structure and function. SmFRET techniques are limited by our 
ability to conjugate specific fluorophores to either RNA or protein, yet retain their normal 
functionality, to study RNA-RNA, RNA-protein and protein-protein interactions. A handful of 
techniques have been developed to conjugate dyes to RNA molecules
109
, but these are 
predominantly for end-labeling RNA molecules. In the case of RNA, we are primarily restricted 
to shorter lengths because of the ease of chemical synthesis and site-specific conjugation with 
dyes. Actin pre-mRNA, which has a 308-nts long intron, has been the choice for traditional yeast 
in vitro splicing experiments. In an effort to find a shorter and more easily synthesizable pre-
mRNA, Ubc4 was identified as suitable for single molecule studies
37
. Ubc4 pre-mRNA has been 
predominantly used in the experiments described in this thesis. This pre-mRNA has the 
advantage of being short (90 nts intron) and yet splicing efficient. This allowed us to synthesize 
the pre-mRNA in two pieces and ligate them to obtain the full-length product. The individual 
pieces were conjugated with fluorophores at the desired splice site locations, upon which they 






pieces were then ligated using T4 RNA ligase 1 with a DNA splint. The ligated product was 
purified away from the remainder of unligated pieces by electrophoresis on a 6% polyacrylamide 
gel (7 M urea). The pre-mRNA band was then carefully excised from the gel and electroeluted 
on a home-built setup to finally extract it. We are still limited in terms of overall yield because of 
the cumulative loss in the multiple steps involved in the process, but can easily produce 
sufficient quantities for single molecule detection. Nevertheless, there is high need for new and 
more efficient labeling methods. 
Fluorescent proteins have swept through world of biology. With the introduction of 
GFP
110
 there has been a leap in the use of fusion protein to understand cellular processes.  Many 
methods have been developed to introduce site-specific, covalently attached labels into proteins; 
however, each method has its own limitation
109
. With over 80 proteins making up the 
spliceosome in yeast, there is no dearth of potential protein labeling targets. The experiments 
presented in Chapter 2 on a labeled single-cysteine mutant of the Cwc25 protein is an example of 
the questions that can be addressed using labeled proteins. To the best of our knowledge, Cwc25-
pre-mRNA FRET experiments are the first of their kind since there has been no other RNA-
protein FRET study in the splicing field. The results point to the idea that Cwc25 binds close to 
the BP, modulating the kinetics required for favorable first-step splicing. There has been a recent 
advance that eliminates the requirement to recombinantly express and purify proteins for 
labeling
77
. The desired advantage is that crude whole cell yeast extracts can be incubated with 
labeling reagent(s) and yet be able to achieve specific labeling of a single protein. Similar 
techniques based on inteins
111






burgeoning demand in fluorescent microscopy, it is imperative that further advances are made in 
the development of new, easy and efficient labeling strategies. 
5.4 A possible mechanism of action for spliceosomal helicases 
The work presented in this thesis spans three important DExD/H box helicases, Prp2 
(Chapter 2), Prp28 (Chapter 4) and Prp16 (Appendix A), which bring about significant 
conformational rearrangements for catalytic activation of the spliceosome. RNA helicases in 
general are characterized by an NTP binding domain and usually use the energy derived from 
hydrolysis to unwind dsRNA. However in vitro strand displacement activity is yet to be 
demonstrated for most of the spliceosome helicases whose direct targets are largely unknown. 
Our results indicate that Prp2 with NTP and protein cofactor Spp2 rearranges the spliceosome-
substrate complex to reversibly explore conformations with proximal 5’SS and BP that 
accommodate chemistry. Similarly, experiments on Prp28 show that the pre-mRNA at this stage 
toggles between two FRET conformations and that Prp28 may drive the equilibrium towards a 
higher FRET state. We thus draw analogy to the ribosome and find the spliceosome to be a 
biased Brownian ratchet machine. In the Brownian motor mechanism, stochastic thermal 
fluctuations in a system allow for a factor to bias the directedness of the process. We believe that 
such a toggling mechanism may be prevalent throughout the spliceosome
94
. In the case of Prp2, a 
stable FRET state seen in the B
act
 pre-mRNA is unlocked by the helicase Prp2, while in the case 
of Prp28, the equilibrium between two FRET states in the CC1 complex is biased towards the 
higher FRET state corresponding to CC2. Thus, the spliceosome in principle can toggle between 






direct evidence yet that this may be the case with other helicases, we believe that a similar 
mechanism is likely operating to facilitate the second step of splicing and that this theme might 
be recurrent in the function of DExD/H box helicases. Interestingly, much like proofreading in 
the ribosome, the toggling seen in here might be the mechanism by which proofreading is 
accomplished in the spliceosome, where each conformational selection by toggling is separated 
by an irreversible step leading to increased commitment as we progress into the splicing cycle.   
This scenario presents interdependent opportunities and challenges for structural and dynamics 
studies in the spliceosome and other biomolecular machines. 
Cell biology is at its most exciting time now. With the development of new and improved 
microscopy techniques and instrumentation, we are able to push the limits of resolution and ‘see’ 
things that were invisible previously. In all likelihood, single molecule methods will continue to 















APPENDIX A: SiMPull-FRET to study pre-mRNA dynamics at the second step of splicing  
 
 
A.1 Reconstitution of the second step of splicing using SiMPull-FRET 
The second step of pre-mRNA splicing involves a transesterification reaction where the 
3’ hydroxyl group of the 5’SS attacks the 3’SS to splice the exons together and to remove the 
intron as a lariat intermediate. In Chapter 2, the roles played by Prp2, Spp2 and Cwc25 in 
facilitating the first step of splicing were shown to involve the remodeling of the B
act
 complex by 
ATPase action of Prp2 and the stabilization of the necessary first-step conformation by Cwc25. 
With the in vitro reconstitution of the second step of splicing, it was demonstrated that the 
essential proteins for this step are Prp16, Prp18 and Slu7
35,100
. The helicase Prp16 is involved in 
the removal of Cwc25 and Yju2 from the BP and remodeling of the C complex
32,100,101,112
. For 
the second step of splicing, the 3’SS needs to be positioned at the catalytic site. This is achieved 
by the ATP-independent action of the Prp18-Slu7 heterodimeric complex
113
. The primary role 
for the helicase Prp22 lies in the ATP-driven disassembly of the spliceosome, with an additional 
ATP-independent role in assisting step 2 catalysis
114
.  
 The nucleotide distance between the BP and 3’SS of the pre-mRNA has been shown to 
play a crucial role in which second step factors are required
100
. For a truncated actin pre-mRNA 






while when the distance is 38 nts, Prp16, ATP, Prp18 and Slu7 are all required for efficient 
product formation
100
. In order to investigate the role played by these factor(s) in restructuring the 
pre-mRNA to bring the 3’SS and 5’SS close together, we decided to use our preferred smFRET 
substrate, Ubc4 pre-mRNA, with fluorophores near the 3’SS and 5’SS. As discussed in Chapter 
2, SiMPull-FRET can be effectively utilized to assign specific pre-mRNA dynamics to specific 
proteins. Using Ubc4 pre-mRNA and heat-inactivatable Prp2 extract (ΔPrp2, Cef-1-TAP), we 
developed a system to reconstitute both steps of splicing starting from the stalled B
act
 complex. 
Immunopurification of the B
act
 complex was achieved as described in Chapter 2, by flowing the 
assembled splicing reaction onto streptavidin coated magnetic beads (Invitrogen) that had been 
pre-incubated with biotinylated IgG. The TAP-tag on the Cef-1 protein binds the protein A 
domain on the immobilized IgG. The complex is then washed under stringent salt conditions to 
obtain a pure complex devoid of any non-specifically bound proteins. The pre-mRNA in the B
act
 
complex alone does not undergo splicing, as expected (Figure A.1, lane 1). Addition of first-step 
factors Prp2, Spp2 and Cwc25 along with ATP leads to efficient first-step products as seen in 
Figure A.1, lane 2. Addition of Prp16 to this complex yielded second-step products albeit at a 
lower efficiency (Figure A.1, lane 3). Furthermore, addition of Prp18 and Slu7 increased the 
second step products by a small factor (Figure A.2, lane 4). Quantification of the free 5’ exon 
released shows that’s there is a slight reduction with the addition of Prp18, Slu7 with respect to 
the pre-mRNA, possibly due to its incorporation into the mature mRNA. Due to high background 
signal, an accurate value for this enhancement could not be reported here.  
 Prp22 has been shown to be not required for second-step reconstitution with actin pre-






with the second step may be in part due to the stepwise addition of second step factors. Our 
results show that for Ubc4, where the distance between the BP and 3’SS is 23 nts, Prp16 seems 
largely sufficient to drive second-step catalysis, while Prp18 and Slu7 only offer a slight 
enhancement, less than what is seen with Cwc25 in the first step. This immunopurified and 
reconstituted system can be used in future SiMPull-FRET experiments to address several 
pertinent questions in the field of splicing. We believe that, like the first step of splicing, the 
second step may also exhibit thermal ratchet-like motion that is locked by a factor in the active 
second-step conformation. To test this, the B
act
 complex needs to be chased as described in 
Chapter 2 to go through the first step of splicing, after which second-step factors can be added 
one at a time to observe what conformational changes each induces in Ubc4 pre-mRNA with 
fluorescent labels near the 3’SS and 5’SS. Additionally, the role played by Prp16 in remodeling 
the spliceosome such that Cwc25 is now displaced from the BP can be explored with 
fluorescently labeled Cwc25 described in Chapter 2. A hypothetical model by which the pre-
mRNA explores two alternative routes to get through step 2 catalysis with the remove Cwc25 to 
is shown in Figure A.3. Our results in Chapter 2 show that in the C complex the 5’SS and BP 
explore stable high FRET states. This could mean that the 3’SS is yet to get coordinated into the 
catalytic center, positioning the 5’ and 3’ exon distal from each other (low FRET state in H
C
 
complex as shown in Figure A.3. In pre-mRNA with a short BP-3’SS distance, Prp16 mediated 
remodeling weakens the binding of Cwc25 to the BP, giving the intron loop the flexibility to 
move out of the catalytic center. This leads to some second-step product formation in substrates 
with short BP-3’SS distance (Step 2* complex). In pre-mRNA with longer BP-3’SS distance, 
removal of Cwc25 is enhanced by Prp18-Slu7
100






step conformation and product formation (Step 2 complex). Binding of Cwc25 does not 
necessarily mean reversal of second step chemistry, since such a role for Cwc25 has not been 
shown. Removal of Cwc25 is necessary for the spliceosome to adopt second step conformation 










Figure A.1 Immunopurification of the Bact complex and reconstruction of the second step 
of splicing 
Reconstitution of second step of splicing with immunopurified B
act
 complexes analyzed on a 
15% polyacrylamide, 7 M urea gel. Immunopurified B
act
 complex (lane 1) is incubated with 
first-step factors Prp2, Spp2, Cwc25 and ATP (lane 2) alone, or additionally with Prp 16 







Figure A.2 Recombinant expression of second-step splicing proteins Prp16, Prp18 and Slu7 
The second-step proteins Prp16, Prp18 and Slu 7 were expressed, purified and analyzed on 













Figure A.3 Model for the mechanism of second step catalysis via pre-mRNA remodeling 
The 3’ and 5’ exons of the pre-mRNA at the C complex are positioned farther apart from 
each other in a stable low-FRET state. Much like Prp2, the helicase Prp16 unlocks this 
state, remodeling the pre-mRNA, thereby allowing the exons to now sample close 
conformational proximity and second step product formation (Step 2* complex). For the 
efficient removal of Cwc25, Prp18-Slu7 heterodimer binds this complex, helping the 
displacement of Cwc25 thereby stabilizing the step 2 conformation and enhancing second 











A.2 Materials and Methods 
Expression and purification of Prp16, Prp18 and Slu7 
Prp16 was cloned into a pET22b plasmid with a C-terminal hexa-histidine tag, Slu7 was 
subcloned from pGEX6P1 into pRsetA plasmid to carry a C-terminal hexa-histidine tag, and 
Prp18 was cloned into a pETM11 plasmid with an N-terminal hexa-histidine tag. The constructs 
were then transformed into Escherichia coli strain Rossetta II (Novagen). Cultures were grown in 
2-4 l of TB medium and induced with 125 μM IPTG. Cultures were then incubated at 20 ºC for 
18 h. Cells were harvested, washed, and the pellets stored at -80 ºC. Purification was performed 
as described
35
. Protein purity was confirmed by 10% SDS-PAGE (Figure A.2) and proteins were 
aliquoted, flash frozen in liquid nitrogen, and stored at -80 ºC. Protein concentrations were 
determined by Bradford assay and measurement at A280.  
 
Immunopurification and second-step reconstitution 
Extracts prepared from prp2-1 cef-1-TAP yeast strain were heated at 37 °C for 40 min to 
inactivate Prp2 and stall the spliceosome at the B
act
 complex. In a final volume of 135 μl, 40% 
(v/v) of this heat treated extract was incubated with ~50 pmoles 3’SS and 5’SS labeled Ubc4 pre-
mRNA in the presence of 2 mM ATP in splicing buffer (8 mM HEPES-KOH, pH 7.0, 2 mM 
MgCl2, 0.08 mM EDTA, 60 mM Ki(PO4), 20 mM KCl, 8% (v/v) glycerol, 3% (w/v) PEG, 0.5 
mM DTT) and incubated at 23 °C for 35 min. Streptavidin-coated magnetic beads were 
incubated with an equal volume of 0.5 mg/ml IgG-biotin in T50 in a tube rotator at RT for 30 






biotin was added to block any streptavidin molecules not yet bound to biotin as described in 
Chapter 2. After equilibration in splicing buffer, the independently assembled splicing reaction 
was added and incubated in a tube rotator for 30 min at RT, followed by washes with buffer A 
and splicing buffer to further purify the B
act
 complex (see Materials and Methods of Chapter 2). 
The reactions are scaled up for reconstitution reactions pursued in parallel and split at this step. 
One part of this B
act
 complex was analyzed on a 15% polyacrylamide gel (Figure A.1, lane 1). To 
the other part, Prp2, Spp2 and Cwc25 were added at 90-120 nM final concentration in splicing 
buffer in the presence or absence of 2 mM ATP and incubated in the tube rotator for 30-40 min. 
At this step, the reaction was split into two aliquots, one of which was loaded into lane 2, 
whereas to the other Prp16 at 80 nM concentration was added in splicing buffer with 2 mM ATP 
and incubated for 30 min. The reaction was once again split into two aliquots, one was loaded 
into lane 3, whereas to the other Prp18 and Slu7 were added at each ~100 nM final concentration 
in splicing buffer and incubated in the tube rotor for 30 min (lane 4). To visualize the products of 
splicing, RNA was isolated and analyzed on a denaturing, 7 M urea, 15% polyacrylamide gel and 











APPENDIX B: Utilizing fluorescently labeled snRNAs to characterize the spliceosome 
 
 
B.1 An in vitro splicing system with fluorescently labeled snRNAs 
The spliceosome is made up of five subunits, each consisting of a single uridine-rich 
small nuclear RNA (snRNA). Assembly occurs in a stepwise manner on the pre-mRNA 
substrate
77
. Various rearrangements and conformational changes take place to finally form the 
catalytically active core of the spliceosome, which consists of the U2, U5 and U6 snRNA:protein 
(snRNP) complexes. During the course of this assembly, pre-mRNA:snRNA interactions are 
disrupted and new ones are created. Despite extensive research in the field, very little is known 
about the timing of snRNA assembly and the pre-mRNA conformational changes accompanying 
it. By establishing a splicing system where the endogenous snRNAs are replaced with 
fluorescent snRNAs, we can in real-time monitor several critical assembly and catalytic steps of 
splicing. Towards this goal, U2, U5 and U6 snRNA were transcribed and fluorescently labeled at 
the 3’ end by coupling with hydrazide derivative of Cy3, Cy5, Alexa488 or TAMRA (Figure 
B.1). Each of the snRNAs could be depleted independently from the wildtype yeast extract using 
previously published complementary DNA oligonucleotides (Chapter 3 and Table B.1).  The 
snRNA-depleted samples were then tested for in vitro splicing by incubating the depleted extract 






snRNAs are essential in the extract for pre-mRNA splicing, upon depletions using 
complementary DNA oligonucleotides pre-mRNA splicing was inhibited, as expected (Figure 
B.2). To these inhibited reactions in vitro transcribed and fluorophore labeled snRNAs were 
added; we were able to restore splicing for U2 snRNA (Figure B.2). Once the conditions for 
depletion and reconstitution for U2, U5 and U6 snRNAs were established, we performed 
smFRET experiments on the system to address specific questions.  
To characterize splice site proximity and the role played by specific snRNAs with respect 
to it, we performed what we term a coincidence analysis to observe pre-mRNA dynamics and 
correlate it with snRNA binding to pre-mRNA. Binding of U2 snRNA is one of the first ATP 
dependent steps in the spliceosome assembly process. We first imaged Ubc4 wildtype pre-
mRNA with Cy3 near the intron, and Cy5 near the BP (Chapters 2 and 3) in the presence of yeast 
whole cell extract depleted of U2 snRNA (to monitor pre-snRNA assembly dynamics). We then 
flowed on whole cell yeast extract reconstituted with U2 snRNA labeled with Cy3 fluorophore at 
its 3’end (to monitor post-snRNA assembly dynamics) (Figure B.3). U2 snRNA was labeled at 
the 3’end because the truncated Δ107 U2 snRNA construct used in these experiments increases 
the proximity between the 3’ end of U2 snRNA and the BP of the pre-mRNA, while it lacks the 
extensive base pairing with U6 snRNA that a full-length 5’ end has. In a converse experiment, 
we were able to observe binding of Cy5-labeled U2 snRNA on the pre-mRNA with a single Cy3 
label near the BP when excited with both red and green lasers (Figure B.4).   
The system presented here has wide applicability. Kinetic information on snRNA 
assembly on the pre-mRNA can be obtained using a similar experimental strategy. Interactions 






fluorescently labeled U2 and U6 snRNA assembled on 5’-biotinylated pre-mRNA in the 
depletion/reconstitution system described, the structural rearrangements between these snRNAs 
to form the catalytic core can be investigated.  Labeling U2 and U6 snRNAs, components of the 
only two snRNPs thought to be involved in catalysis, can be used to gain insights into the much-




 by visualizing the time-dependent 
assembly of U2 and U6 snRNA on the pre-mRNA substrate. The experiments described here 















Figure B.1 Fluorescent labeling of U5snRNA via 3’-periodate oxidation 
15% polyacrylamide, 7 M urea gel showing fluorescently labeled U5 snRNA. From left to 
right, lane 1 is free Cy5 dye (marked with a black star), lane 2 shows Cy5 labeled 
U5snRNA and lane 3 shows U5 snRNA labeled with TAMRA fluorophore (black arrow 









Figure B.2 Reconstitution of snRNA depleted extracts with fluorescently labeled snRNA. 
(a) Schematic showing RNaseH mediated degradation of snRNA-DNA hybrid and 
reconstitution with Cy3 labeled snRNA (green circle). (b) 15% polyacrylamide, 7 M urea 
gel showing wildtype snRNA (WT snRNA, unmodified), U2 snRNA -, depleted and +, 
reconstituted with Cy3-labeled U2 snRNA, U6snRNA -, depleted and +, reconstituted with 
Cy3-labeled U6snRNA in the presence or absence of ATP (+/-). Efficient splicing is 
achieved upon reconstitution with labeled snRNA as indicated by the splicing products 










Figure B.3 Assembling Cy3-labeled U2 snRNA on doubly labeled (Cy3-Cy5) pre-mRNA. 
(a) Schematic of the experimental setup showing immobilized pre-mRNA (with Cy3 near 
the BP and Cy5 near the 5’SS) on a slide surface in extract depleted of U2 snRNA and 
extract reconstituted with Cy3-U2 snRNA. (b) Representative smFRET trajectories from 
the experiment showing the assembly of Cy3-U2snRNA on pre-mRNA (blue, Cy3 signal; 
red, Cy5 signal). The presence of two Cy3 fluorophores (one on the U2 snRNA and the 









Figure B.4 Single molecule binding experiment with Cy5-U2 snRNA and Ubc4 pre-mRNA. 
(a) Schematic of a binding experiment showing Cy5-labeled U2 snRNA binding to Ubc4 
pre-mRNA labeled with a single Cy3 fluorophore. (b) Representative traces from this 













B.2 Materials and Methods 
Plasmids used 
Plasmids for U2, U5 and U6 snRNA (cloned in pUC18) were obtained from the Guthrie 
lab at the University of California, San Francisco. U2 and U6 snRNA plasmids have a T7 
promoter upstream of the snRNA sequence. U5 snRNA plasmid was cloned into the pUC18 
without the T7 promoter. The length of U2, U5 and U6 are 307, 220 and 120 nts, respectively. 
PCR amplification and in vitro transcription 
U5 snRNA was amplified from the plasmid using a forward primer with a T7 promoter 
and a reverse primer. The PCR product was analyzed on a 1% agarose gel and subsequently gel 
purified. This DNA template was then used directly for standard in vitro transcription reactions. 
U2 and U6 snRNA were linearized using restriction enzymes Afl1 and Dra1, respectively, with 
cleavage sites located at the 3’ end of the snRNA sequences. The product was analyzed on a 1% 
agarose gel and subsequently gel eluted. Transcription reactions were then carried out on this 
template using home-made T7 polymerase and buffer. The transcription reaction were carried 
out for 8 h at 37 ºC and treated with DNase enzyme to digest the DNA template. The products of 
the transcription were run out on a 15%, 7 M urea PAGE, gel eluted using 1 mM EDTA and 
precipitated using 300 mM sodium acetate, pH 5.3, and 2.5 volumes of 100% ethanol. 
Periodate oxidation and Cy3/Cy5/Alexa488-hydrazide coupling of snRNA 
To fluorescently label the snRNAs, we used periodate oxidation of the 3’ terminal ribose 
followed to couple the RNA with Cy3, Cy5 or Alexa488-hydrazide (GE life sciences) as 
described
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on a 15%, 7 M urea PAGE. The bands were eluted using standard protocol (see above) and 
ethanol precipitated.  
DNA oligonucleotides for U2 and U6 snRNA depletion 
U2 and U6 snRNA were depleted using DNA oligonucleotides complementary to 
specific accessible regions. DNA oligonucleotide SRU2 was hybridized to U2 snRNA and DNA 
oligonucleotide D1 was hybridized to U6 snRNA.  The sequence of SRU2 and D1 are shown in 
Table B.1. Wildtype yeast cell extracts were incubated with 450 nM of SRU2 and 300 nM of D1 
independently for 30 min at 33 ºC in the presence of 3.3 mM ATP. Depletions were tested using 
the in vitro splicing reaction conditions described above and the products analyzed on a 15%, 7 
M urea PAGE for splicing. 
Reconstitution of splicing 
Yeast cell extract depleted of endogenous U2 and U6 snRNA was reconstituted with 15 
nM and 10 nM concentrations of in vitro transcribed and 3’ fluorophore labeled U2 and U6 
snRNA, respectively. The ability of the reconstituted system to direct pre-mRNA splicing was 
tested using the in vitro splicing reaction conditions described above and the products analyzed 












SRU2 (anti U2 snRNA) 5’-CAGATACTACACTTG-3’ 
D1 (anti-U6 snRNA) 5’-CATCTCTGTATTGTTTCAAATTGACCAA-3’ 
 
























PCR amplification, in vitro transcription and fluorophore coupling 
U2 and U6 snRNA plasmids were linearized and in vitro transcriptions were performed 
using T7 polymerase to generate the respective snRNAs (data not shown). U5 snRNA plasmid 
was PCR amplified using a T7 promoter added to the forward primer. The product of the PCR 
reaction was used to obtain U5 snRNA via in vitro transcription. Periodate oxidation and 
coupling with the hydrazide derivative of the desired fluorophore yielded the labeled snRNAs 
shown in Figure B.3. 
U2 and U6 snRNA depletion and reconstitution reactions 
Splicing cell extracts were depleted of their endogenous U2 and U6 snRNAs using 
complementary DNA oligonucleotides as described (Chapter 3) and reconstituted with in vitro 
transcribed and fluorescently labeled U2 and U6 snRNA to reconstitute splicing as visualized by 
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